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ABSTRACT
Components of G protein-mediated signaling are associated with positioning and orienting the
mitotic spindle in the process of cell division. However, a functional role for G protein signaling
modulator 3 (GPSM3) in cell division has yet to be defined. The purpose of this study was to
investigate a potential role for GPSM3 in cell division. Vascular smooth muscle cells (VSMCs)
from Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats, that are known to
express GPSM3, were used as a model system. Here I report that GPSM3 mRNA and protein
levels varied during different stages of the cell cycle in SHR VSMCs. In HEK-293 cells,
overexpressing GPSM3 resulted in an increased rate of proliferation. Finally, during metaphase,
anaphase, and telophase, GPSM3 and β-tubulin co-localize at the mitotic spindle and midbody.
Overall, this study provides evidence of a role for GPSM3 in cell division, likely via an
interaction with the mitotic spindle.

KEYWORDS
G protein-mediated signaling, G protein signaling modulator 3 (GPSM3), cell division,
proliferation, mitotic spindle, vascular smooth muscle cell (VSMC)
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1 INTRODUCTION

The functional role of G protein signaling modulator 3 (GPSM3) in mammalian cells remains
poorly understood relative to other components of the G protein-mediated signaling machinery. I
hypothesize that GPSM3, like other G protein-mediated signaling components, plays a role in the
process of cell division, likely via an as yet undefined interaction with the mitotic spindle. The
purpose of this study is to investigate this potential role in a vascular smooth muscle cell
(VSMC) model system.

1.1 G PROTEIN SIGNALING
1.1.1 G PROTEIN SIGNALING OVERVIEW

Guanine nucleotide-binding protein (G protein)-mediated signaling is a preeminent mechanism
used by cells to communicate with each other and sense environmental changes. Canonically,
signaling occurs through three main protein components: a G protein-coupled receptor (GPCR),
a heterotrimeric G protein (Gαβγ), and an effector (Neves et al. 2002; Ferguson 2001; Jacoby et
al. 2006) (Figure 1.1). Briefly, when a GPCR is activated by its ligand, it promotes the exchange
of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) by the α subunit of the
heterotrimeric G protein. This in turn is thought to promote the dissociation of the Gα and Gβγ
subunits, which are then free to independently shuttle to and interact with downstream effectors.
Examples of effectors include adenylyl cyclase (AC), which plays a central role in the cyclic
adenosine monophosphate (cAMP) signal pathway, and phospholipase Cβ (PLCβ), which
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Figure 1.1. Receptor-mediated activation of heterotrimeric G proteins. The binding of the
extracellular ligand to the receptor causes a conformational; change of the receptor, which leads
to the activation of the Gα subunit. This activation promotes the exchange of GDP for GTP and
is thought to cause the dissociation of the Gβγ dimer from the complex. Both the GTP-bound Gα
and Gβγ subunit are capable of initiating signals by interacting with downstream effectors. The
process is terminated by the GTPase activity of the Gα subunit that can hydrolyze GTP to GDP,
returning the Gα subunit to its inactive form and promoting the reformation of the Gαβγ
heterotrimer complex.

3
triggers the phosphatidylinositol/diacylglycerol signal pathway (Neves et al. 2002; Smrcka
2008). Eventually, the intrinsic guanosine triphosphate phosphohydrolase (GTPase) activity of
Gα will hydrolyze the bound GTP molecule, which results in the reformation of the Gαβγ
complex and terminates GPCR signaling.

1.1.2 G PROTEIN COUPLED RECEPTORS

GPCRs are the largest superfamily of receptors in the human genome and approximately 30% of
currently marketed prescription pharmaceuticals act on GPCRs, making them the most common
and historically successful therapeutic target family (some reports place this number closer to
50%) (Jacoby et al. 2006; Overington et al. 2006; Kobilka 2007). These receptors transduce a
wide variety of extracellular signals, including hormones, autocrine and paracrine factors,
chemokines, and neurotransmitters, to the interior of the cell (Neves et al. 2002). GPCRs share a
specific structural organization: seven membrane-spanning domains or transmembrane alpha
helices connected by three intracellular loops and three extracellular loops, an N-terminal
extracellular tail, and a C-terminal intracellular tail (Jastrzebska 2013). Many GPCRs also
possess an eighth alpha helix attached by a linker to helix seven that runs parallel to the inside of
the phospholipid bilayer which can influence G protein recognition (Kaye et al. 2011).

When a GPCR is activated by a ligand, typically via binding in a cavity formed between the
transmembrane helices, conformational changes occur at its cytoplasmic surface that reveal
residues in the intracellular loops and in the transmembrane helices that lead to G protein
activation (Jastrzebska 2013; Trzaskowski et al. 2012). GPCRs activate G proteins by acting as
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guanine nucleotide exchange factors (GEF), promoting the exchange of GDP for GTP on the Gα
subunit (Siderovski & Willard 2005). Activated GPCRs can be phosphorylated by G proteincoupled receptor kinases (GRKs), and that promotes their association with β-arrestins (Ferguson
2001; DeWire et al. 2007). These proteins block GPCR signaling through a steric mechanism
and bring the receptors to clathrin-coated pits for internalization. Once internalized in
endosomes, GPCRs can undergo degradation, continue signaling via G protein-independent
mechanisms, or be recycled back to the plasma membrane. While this traditional view of GPCRs
begins to outline their function, there are numerous additional facets to the story that illustrate
the complexity of this process including the now widely accepted phenomenon of GPCR
oligomerization and the evidence for receptor-G protein-effector complexes (Jastrzebska 2013;
Chidiac 1998).

1.1.3 DIVERSITY OF Gα PROTEINS AND SIGNALING

Up to the present time, 23 Gα subunit isoforms have been identified (McIntire 2009; Preininger
& Hamm 2004). Gα subunits belong to a family of membrane-associated GTPases that function
as molecular switches to control a wide array of cellular processes, and have been placed into
four distinct subfamilies based on their sequence similarity and effector selectivity: Gs, Gi/o,
Gq/11, and G12/13 (Neves et al. 2002; Zhao et al. 2013) (Table 1.1) (Figure 1.2). Gs subunits
(Gαs, Gαolf) can stimulate AC activity, increasing cAMP production (Neves et al. 2002). This
second messenger is capable of regulating proteins such as cAMP-dependent protein kinase
(PKA), cAMP-dependent GEFs for calcium channels and a small GTPase known as Ras-related
protein 1 (Rap1) (Weinstein et al. 2004; Neves et al. 2002). Gαs has also been found to interact
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Table 1.1. Classes of Gα subunits, their expression pattern, and their effectors.
Gα family
Gαs

Gαi/o

Gαq/11

Gα12/13

Gα
subunit
Gαs

Expression Profile

Effectors

Ubiquitous

Stimulation of adenylyl cyclase

Gαolf

Olfactory neurons

Stimulation of adenylyl cyclase

Gαi1/2/3

Ubiquitous

GαoA/B

Brain

Gαt1/2

Retina

Gαz

Brain/platelets

Gαq/11

Ubiquitous

Gα15/16

Hematopoietic cells

Gα14

Lung, kidney, liver

Gα12/13

Ubiquitous

Inhibition of adenylyl cyclase, Ca2+
channel closure
Inhibition of adenylyl cyclase, Ca2+
channel closure
Stimulation of cGMPphosphodiesterase
Inhibition of adenylyl cyclase, K+
channel closure
Stimulation of PLC-β, Activate
RhoGEFs*
Stimulation of PLC-β, Activate
RhoGEFs*
Stimulation of PLC-β, Activate
RhoGEFs*
Activate RhoGEFs*

* RhoGEFs activated by Gα12/13 and Gα14 are distinct.
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Figure 1.2. Regulation of systemic functions by signaling through G protein pathways. A
schematic representation of how signaling through G protein pathways can regulate systemic
functions. From Neves et al. 2002. Reprinted with permission from AAAS.
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with tubulin in lipid rafts and can be internalized via lipid raft-derived vesicles (Dave et al.
2009). Members of the Gi/o subfamily (Gαi1, Gαi2, Gαi3, Gαo, Gαz, Gαt) exhibit inhibitory
effects on AC activity, thereby decreasing cAMP production (Neves et al. 2002). Gαi/o subunits
also play an important role in the process of cell division. The Gαi and Gαo subunits can be
inhibited by pertussis toxin, which adenosine diphosphate (ADP)-ribosylates Gαi/o subunits at
their COOH-terminal region preventing them from interacting with a GPCR (Neves et al. 2002).
Gq subunits (Gαq, Gα11, Gα14, Gα15, Gα16) primarily act on PLCβ leading to the production
of two intracellular second messengers, inositol triphosphate (IP3) and diacylglycerol (DAG),
and via these the regulation of the release of intracellular calcium stores and the activity of
protein kinase C (PKC), respectively (Neves et al. 2002; Rhee & Bae 1997). The effectors of
G12/13 subunits (Gα12, Gα13) are not yet well understood, but have been shown to regulate
Rho, a member of the Ras superfamily, and Rho-kinase activation via RhoGEFs (Neves et al.
2002).

1.1.4 STRUCTURAL BASIS OF Gα PROTEIN ACTIVATION

Gα protein subunits consist of a catalytic (Ras-like or GTPase) domain, a six-helix bundle
domain (helical domain), and two flexible linker regions (linkers 1 and 2), connecting these two
domains whose interface forms a deep cleft which functions as a GDP binding pocket (Figure
1.3) (Khafizov 2009; Lambright et al. 1994). The GTPase domain is made up of five helices (α1α5) surrounding a six-stranded β sheet (β1-β6), while the helical domain is comprised entirely of
α-helical secondary structures with one long central helix (αA) encompassed by five shorter
helices (αB-αF) (Lambright et al. 1994). The three flexible loops (Switches I, II, and III) within
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Figure 1.3. Structural features of heterotrimeric G proteins. (a) Ribbon model of
Gαi(GDP)β1γ1 heterotrimer. (b) The subunits have been rotated to show the intersubunit
interface. From Oldham & Hamm 2006. Reprinted with permission from Cambridge University
Press.

9
the GTPase domain undergo dramatic structural changes during the nucleotide exchange and
hydrolysis cycle (Lambright et al. 1994; Mixon et al. 1995). The GTPase domain also contains
binding sites for various receptors and effectors, as well as Gβγ. An α-helical lid, part of the
helical domain, is positioned over the nucleotide binding site, burying the bound nucleotide in
the core of the protein (Lambright et al. 1994; Warner et al. 1998). The helical domain is the
most divergent domain among the Gα subunit families and therefore is thought to regulate
binding of Gα subunits to receptors and other regulators (Liu & Northup 1998).

Upon activation by a ligand, it has been suggested that the GPCR uses the N-terminal helix of
Gα to “pull” the Gβγ dimer and switch I and II regions away from the nucleotide binding pocket,
resulting in GDP release (Iiri et al. 1998). Non-receptor GEFs such as resistance to inhibitors of
cholinesterase 8 (Ric-8) work in a similar manner, promoting the pivoting of the helical and Raslike domains away from each other and structural rearrangement of the switch I and II regions to
allow for nucleotide exchange (Van Eps et al. 2015). The Gα subunit most likely exists in a
transient nucleotide-free state before binding of GTP, which exists at a much higher
concentration in the cell relative to GDP (Smrcka 2008). The binding of GTP results in structural
rearrangement of the heterotrimeric G protein that exposes the Gα subunit’s effector binding site,
thus leading to signal transduction. The duration of G protein signaling is determined by the
length of time that the Gα subunit is in its GTP-bound state (Ross & Wilkie 2000). The intrinsic
GTP hydrolysis activity among the different Gα protein subunits varies, although it is relatively
slow in all cases compared to when it is stimulated by GTPase-accelerating proteins (GAP),
which often occurs (Oldham & Hamm 2006). Structural studies have demonstrated the
importance of the three switch regions in GTP hydrolysis, and inspection of the crystal structure
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of fluoroaluminate-activated Gα protein subunit reveals a functional role of conserved glutamine
and arginine residues within the nucleotide-binding pocket (Coleman et al. 1994; Noel et al.
1993; Sondek et al. 1994).

1.1.5 DIVERSITY OF Gβγ SIGNALING

Gβ and Gγ subunits, tethered to the membrane by fatty acyl modification of Gγ, essentially
function as dimers since the Gβγ complex is highly stable and only comes apart under denaturing
conditions (Zhao et al. 2013; Neves et al. 2002). Up to the present time, 7 β subunit and 12 γ
subunit isoforms have been identified (McIntire 2009). The first five β subunits are the most well
studied, with the first four sharing greater than 80% amino acid sequence identify versus the fifth
with 50% identity, and significantly lower identity amongst the γ subunits (Smrcka 2008). These
different subunit isoforms can pair to form unique combinations; some combinations have been
associated with specific receptors, but overall the significance of this diversity remains poorly
understood (Kleuss et al. 1992; Kleuss et al. 1993).

Pertussis toxin (PTX)-dependent catalysis of adenosine diphosphate (ADP) ribosylation of Gαi/o
subunits prevents their interaction with and activation by GPCRs (Burns 1988). Many of the
GPCR-dependent physiological processes that are inhibited by PTX are mediated by Gβγ
subunits rather than Gα subunits, and this accounts for the majority of known Gβγ-dependent
signaling. Therefore it follows that the majority of Gβγ-dependent signaling appears to result
from Gβγ dimers originally complexed with Gαi/o protein subunits (Smrcka 2008).
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Gβγ is required for receptor-stimulated activation since it stabilizes Gα-receptor coupling, and
has even been reported to bind to the receptor (Zhao et al. 2013; Smrcka 2008). Gβγ dimers also
act as guanine nucleotide dissociation inhibitors (GDI), slowing down the intrinsic rate of GDP
dissociation from the Gα subunit by up fifty fold, as well as functioning to increase the rate of
association of GDP (Gilman 1987). Gβγ targets a large number of effectors both directly and
indirectly, including G protein-coupled inwardly rectifying K+ (GIRK) channels, PLCβ, AC, and
various kinases and calcium channels (Smrcka 2008; Rhee & Bae 1997) (Table 1.2). Gβγ
specificity for receptors and effectors is poorly understood, but suggested mechanisms include
tissue-specific expression, restricted subcellular localization, and precoupling of components
(Smrcka 2008).

1.1.6 STRUCTURAL BASIS OF Gβγ SIGNALING

The Gβ subunit folds into a protypical β-propeller made up of four-stranded β-sheets forming
each of the seven blades of the propeller (Smrcka 2008) (Figure 1.3). An α-helical domain,
comprised of the first 57-70 amino acids N-terminal to the β-propeller, forms a tight coiled-coil
interaction with the Gγ subunit (Smrcka 2008). The β-sheets of the propeller and the variable
loops connecting the β strands are the most highly conserved regions of the protein (Smrcka
2008). Gα subunits interact with Gβγ via two independent structural elements: the N-terminal αhelix of the Gα subunit interacts with the first blade of the β-propeller at its side and the Gα
switch II region interacts with the top of the β-propeller (Smrcka 2008). Upon GTP binding, the
switch II region undergoes conformational changes, but little difference in structure is seen in
Gβγ upon release from Gα (Smrcka 2008). This supports a theory that rather than dissociate, the
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Gαβγ heterotrimer simply undergoes a rearrangement during G protein activation. However, the
more generally accepted theory of complete dissociation asserts that during activation both
interfaces between Gα and Gβγ are broken. In either case, traditionally it is taken that when
bound to Gα(GDP), Gβγ cannot activate downstream effectors and thus Gβγ-mediated signaling
relies on nucleotide exchange on the Gα subunit (Scott et al. 2001). In a sense, Gα(GDP) and
Gβγ are locked in a mutually inhibitory embrace with one another. However, an apparent second
Gβγ binding site on Gαi/o subunits, which is distant from the primary site and does not compete
with the principal effector binding site, suggests that a Gαi/o(GDP)-(Gβγ)2 complex could
associate with effectors (Wang et al. 2009).

The absence of a catalytic site on Gβγ means that it acts as a modulator through regulated
protein-protein interactions (Smrcka 2008). It has been suggested that the majority of these
interactions occur at a single interaction “hot spot”, which through the use of key energetic
residues mediates multiple types of chemical interactions (hydrophobic, ionic, etc.) without strict
geometric requirements for binding, thus accommodating multiple structural and chemical motifs
(Scott et al. 2001; Smrcka 2008).

1.1.7 KINETIC REGULATION OF G PROTEIN ACTIVITY

The kinetics of the G protein activation and deactivation reactions play a major role in G proteinmediated signaling. G proteins are normally found in the GDP-bound state and thus the first step
in the cycle of nucleotide exchange at the Gα subunit is GDP dissociation. The relatively high
concentration of GTP in cells (both absolute concentration and relative concentration compared
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to GDP) ensures a rapid association of the nucleotide-free G protein with GTP (Smrcka 2008).
This means that GDP dissociation is the rate-limiting step of nucleotide exchange. GTP is
typically hydrolyzed before it dissociates, thus beginning the cycle again. Three classes of
regulators collaborate to tightly control the kinetics of G protein signaling: GAPs, GEFs, and
GDIs (Figure 1.4).

GAPs such as the regulator of G protein signaling (RGS) proteins can increase GTP hydrolysis
rates by up to 2000 fold (Mukhopadhyay & Ross 1999). Consequently, GAP proteins negatively
regulate the G protein cycle by dampening signal output and by rapidly terminating G protein
activation following the removal of the stimulus. It is also suspected that GAP proteins, namely
RGS proteins, are able to potentiate receptor-mediated activation via a proposed kinetic
scaffolding mechanism whereby they reduce depletion of Gα(GDP) levels in order to ensure
rapid recoupling to the receptor and sustained G protein activation (Biddlecome et al. 1996;
Zhong et al. 2003). They could potentially even directly or indirectly interact with GPCRs during
nucleotide exchange (Lambert et al. 2010; Popov et al. 2000).

GEFs such as GPCRS dramatically increase the rate of GDP dissociation, leading to an increase
in GTP association and G protein activation. Non-receptor GEFs such as Ric-8 share similar
mechanisms with that of the receptor, promoting the dissociation of both GDP and GTP (Chan et
al. 2011). At high GTP concentrations, such as those found intracellularly (~150 µM), GTP
association is greater than dissociation and Gα(GTP) predominates (Chan et al. 2011).
Interestingly, Ric-8B has also been reported to seemingly stabilize G proteins in their nucleotide-
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Figure 1.4. Regulation of G protein cycle. The rate of nucleotide exchange can be altered by
guanine nucleotide exchange factors (GEFs) and guanine nucleotide dissociation inhibitors
(GDIs). GTP hydrolysis can be regulated by GTPase accelerating proteins (GAPs).
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free conformation, preventing them from denaturing and thereby increasing cellular G protein
levels (Tall 2013).

Finally, GDIs such as Gβγ retard the already relatively slow rate of GDP dissociation from Gα
(Zhao et al. 2013). Proteins containing the G protein signaling modulator (GPSM) motif, also
known as a G protein regulatory (GPR) motif or a GoLoco (Gαi/o-Loco) motif, are the best
studied group of proteins with GDI activity (Granderath et al. 1999; Siderovski et al. 1999; Zhao
et al. 2013). It has been reported that the rate of guanosine 5’-O-[gamma-thio] triphosphate
(GTPγS, a GTP analog which dissociates slowly and cannot be hydrolyzed to GDP) binding is
decreased up to 80% in the presence of GPSM proteins (including GPSM3) or peptides derived
from the GPSM motifs of RGS12 and RGS14 (Zhao et al. 2010; Windh & Manning 2002). They
accomplish this by directly interacting with and stabilizing Gα(GDP). These three groups of
accessory proteins fine-tune G protein signaling, and as discussed below they have a wide range
of other functions in the cell as well.

1.2 GPSM MOTIF-CONTAINING PROTEINS
1.2.1 IDENTIFICATION AND CHARACTERIZATION OF GPSM MOTIF-CONTAINING
PROTEINS

The first GPSM motif identified is in loco, a RGS12 homologue found in Drosophila
melanogaster and associated with impaired locomotor capabilities (Granderath et al. 1999). Cterminal to its RGS domain the researchers identified a G protein interaction site, and this
observation led to the discovery of several other proteins that shared this highly conserved 19
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amino acid motif (Granderath et al. 1999; Siderovski et al. 1999). This motif was also quickly
demonstrated to be a receptor-independent activator of Gβγ signaling. A yeast-based functional
screen was used to take advantage of this, which tested a mammalian library for cDNAs
encoding proteins that activate the pheromone response pathway in the absence of a GPCR. This
led to the discovery of the AGS proteins, many of which contain at least one GPSM motif
(Takesono et al. 1999; Cao et al. 2004).

The GPSM motif has a relatively high affinity for GDP-bound Gα compared to nucleotide-free
or GTP-bound Gα, stabilizing this form and slowing down spontaneous nucleotide exchange
(Kimple, Willard, et al. 2002; Kimple, Kimple, et al. 2002; Siderovski & Willard 2005). A
significant conformational change of the switch region of the Gα subunit is induced upon
binding of a GPSM domain, making Gα(GDP)-Gβγ and Gα(GDP)-GPSM complexes mutually
exclusive (Bernard et al. 2001; Siderovski & Willard 2005). A GPSM motif consensus peptide
that was derived from GPSM1, also known as activator of G protein signaling (AGS) 3, inhibits
Gα(GDP) from binding to Gβγ ten times more effectively than the Gβγ hot spot-binding peptide
(SIGK, which also interferes with the binding between Gβγ and Gα) (Ghosh et al. 2003).
Additionally, this peptide was shown to cause rapid dissociation between Gβγ subunits and Gα
subunits at a rate 13-fold higher than the intrinsic rate of Gα (Ghosh et al. 2003). Full-length
RGS14 failed to disrupt G protein heterotrimers in vitro or in cells, but a peptide derived from
the RGS14 GPSM motif prevented the reformation of Gαβγ heterotrimers (Mittal & Linder
2006; Webb et al. 2005). While the GPSM motif seems to consistently prevent reassociation of
subunits, its ability to promote dissociation appears to depend on the cellular or experimental
context and the GPSM motif-containing protein in question.
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1.2.2 DIVERSITY OF GPSM MOTIF-CONTAINING PROTEINS

The diverse collection of GPSM-motif containing proteins is currently divided into four distinct
families: 1) the RGS and Ras-binding domain (RBD) proteins RGS12, RGS14, and Drosophila
Loco, each of which contains a single GPSM motif, 2) the multiple tetratricopeptide repeat
(TPR) motif proteins GPSM1/AGS3, GPSM2/LGN, Drosophila Partner of Inscuteable (Pins),
and Caenorhabditis elegans GPR-1 and GPR-2, which contain one to four GPSM motifs, 3) the
relatively small proteins GPSM3/G18/AGS4 and GPSM4/Pcp-2, which contain three and two
GPSM motifs, respectively, and 4) Rap1GAP, which contains a single GPSM motif at its Nterminus (Figure 1.5).

The majority of the GPSM motifs interact mainly with Gαi and Gαo with varying affinities,
however some also interact with other G proteins (Zhao et al. 2010; Mittal & Linder 2006;
Willard et al. 2006; Willard et al. 2007). GPSM1, for example, interacts with Gαt and blocks
rhodopsin-induced dissociation of GDP (Natochin & Artemyev 2000). Therefore, the GPSM
motif can be said to interact with G proteins from the Gαi/o subunit family. As many of these
proteins contain multiple GPSM motifs, they are capable of binding multiple Gα subunits at one
time (Bernard et al. 2001; Adhikari & Sprang 2003; Kimple et al. 2004; Jia et al. 2012). It
appears that in GPSM1, cooperative binding of Gα subunits among its GPSM motifs occurs
(Adhikari & Sprang 2003). Conversely, competitive binding among the GPSM motifs in Pins has
been demonstrated and is thought to contribute to ultrasensitivity in regulatory pathways (Smith
& Prehoda 2011).
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GPSM1/AGS3
GPSM2/LGN/AGS5

GPSM3/G18/AGS4
GPSM4/Pcp-2
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Figure 1.5. Diversity of GPSM motif-containing proteins. The GPSM motif, also known as
the GPR motif or GoLoco motif, is found singly or in tandem arrays in a number of different
proteins. Domain abbreviations are G protein signaling modulator, GPSM; PSD-95/Discs
large/ZO-1 homology domain, PDZ; phosphotyrosine-binding domain, PTB; regulator of G
protein signaling domain, RGS; Ras-binding domain, RBD; Rap-specific GTPase-activating
protein domain, RapGAP; tetratricopeptide repeat, TPR. Asterisk denotes N-terminal variation of
GPSM motif sequence between isoforms I and II of Rap1GAP.

19
1.2.3 MOLECULAR BASIS FOR THE GDI ACTIVITY OF GPSM MOTIF- CONTAINING
PROTEINS

The crystal structure of the GPSM motif in RGS14 associated with Gαi1 demonstrates the
significance of both the Asp/Glu-Gln-Arg triad (or acidic-glutamine-arginine triad) of the GPSM
motif and the switch II region of the Gα subunit (Kimple, Kimple, et al. 2002) (Figure 1.6). The
N-terminal α-helix of the GPSM peptide inserts between the switch II and α3 helix regions of the
Gα subunit, displacing these two regions away from each other and in the process deforming the
normal site of Gβγ association. The side chain of the arginine finger within the acidic-glutaminearginine triad, which defines the final residues of the conserved 19 amino acid GPSM motif
signature, reaches into the nucleotide binding pocket of Gα and makes direct contact with the α
and β phosphate of the bound GDP via its basic δ-guanididium group (Kimple, Kimple, et al.
2002; Siderovski & Willard 2005; Thomas et al. 2008). It has also been shown that the binding
of the GPSM motif displaces an arginine within the switch I region of Gα, and instead of
contacting the α and β phosphate groups it contacts the 3’ hydroxyl group of the GDP ribose
sugar moiety (Willard et al. 2004). This newly formed interaction is believed to underlie the GDI
activity of the GPSM motif.

Mutation of the arginine in the acidic-glutamine-arginine triad to phenylalanine results in the
complete loss of GDI activity and the ability to bind Gαi/o subunits, while mutation to less bulky
alanine or leucine residues causes a significant decrease in GDI activity but no change in binding
affinity
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Figure 1.6. The GPSM motif of RGS14 interacts with Gαi1. Ribbon drawing of R14GL
peptide (red) in contact with the Ras-like (green) and all-helical (yellow) domains of Gαi1. Also
shown are the three switch regions of Gαi1 (blue), GDP (magenta), and Mg2+ (orange). From
Kimple, Kimple, et al. 2002. Reprinted with permission from Nature Publishing Group.
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(Kimple, Kimple, et al. 2002; Peterson et al. 2000; Takesono et al. 1999; Peterson et al. 2002;
Bernard et al. 2001). This means that the arginine of the acidic-glutamine-arginine triad is a
significant, but not an absolute, determinant of guanine nucleotide dissociation inhibitor activity
(Willard et al. 2004). The glutamine residue preceding it is also a crucial determinant of GDI
activity, forming extensive backbone interactions with the Gα subunit which kinks the GPSM
motif peptide backbone allowing the arginine side chain to fully extend into the nucleotidebinding pocket (Kimple, Kimple, et al. 2002; Willard et al. 2004). Mutating this residue to
alanine eliminates GDI activity and Gα binding (Peterson et al. 2002). Finally, the acidic residue
preceding glutamine is important for structurally anchoring glutamine via a side chain hydrogen
bond (Willard et al. 2004).

The selectivity of the various GPSM motifs for G proteins is determined principally by the allhelical domain of the Gα subunit and residues C-terminal to the conserved 19 amino acid core
GPSM motif. A Gαo-insensitive GPSM motif peptide derived from RGS14 and GPSM1
exhibited GDI activity on a chimeric Gαo subunit containing the all-helical domain of Gαi1
(Kimple, Kimple, et al. 2002). Alternatively, replacing the C-terminal domain of RGS14 with the
corresponding region from Pcp-2, a GPSM motif-containing protein that is sensitive to Gαo,
leads to a gain of function similar to wild-type Pcp-2 (Kimple, Kimple, et al. 2002).
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1.2.4 REGULATION OF GPSM MOTIF FUNCTION

Although the regulation of GPSM motif function remains poorly studied, a few forms of
regulation have been identified. Most GPSM motif-containing proteins contain at least one
phosphorylation site located within or N-terminal to the core GPSM motif, which theoretically
could affect their function. Phosphorylation of the PKA substrate Thr-494 just N-terminal to the
GPSM motif of RGS14 results in increased GDI activity by up to three fold (Hollinger et al.
2003). Phosphorylation of the GPSM motifs in GPSM1 by LKB1, on the other hand, reduces its
ability to interact with G proteins (Blumer et al. 2003). Phosphorylation of the Thr-450 site Nterminal to the first GPSM motif in GPSM2 by PBK/TOPK leads to enhanced cell growth
(Fukukawa et al. 2010a). Whether this effect is related to G protein signaling or the Gα-GPSM2NuMA ternary complex is unclear. It therefore appears that phosphorylation is a commonly used
means to regulate GPSM motif-containing proteins (Blumer et al. 2007).

Expression of some GPSM motif-containing proteins appears to be developmentally regulated.
GPSM1 mRNA levels in the heart change during the course of development, and expression has
been shown to decline in the aging rat brain (Pizzinat et al. 2001; Blumer et al. 2002). GPSM1 is
also upregulated in the brain of a rat model of craving following cocaine exposure (Bowers et al.
2004). GPSM2 expression has been reported to change with the cell cycle (Whitfield et al. 2002;
Du & Macara 2004).

Regulation via the activation of GPCRs has also been demonstrated. Activation of the α2
adrenergic receptor (α2-AR) or the µ-opioid receptor greatly diminishes the bioluminescence
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resonance energy transfer (BRET) signal observed between GPSM1 and Gαi. Interestingly, coexpression of RGS4 in this overexpression system inhibits this effect, suggesting that both
nucleotide exchange and hydrolysis play a role in this regulatory effect (Oner, An, et al. 2010).
Coupling between GPSM3 and Gαi is also reported to be reduced upon activation of the α2-AR
(Oner, Maher, et al. 2010). Recently, evidence has been found that this regulation may be the
result of direct coupling of a GPSM-Gα(GDP) complex with a GPCR, suggesting this could
represent a unique signaling triad that parallels the well-defined heptahelical receptor-Gαβγeffector system (Robichaux et al. 2015). This study used a version of Gαi2 that was mutated to
be pertussis toxin-insensitive and tethered to α2-AR. Pertussis toxin was used to ensure that only
the tethered Gα subunits were being tested. When bound by either GPSM3 or GPSM1, agonist
activation was shown to reduce BRET signals between both of these proteins and Gαi2 by up to
40%. This is an intriguing result as many GPSM-motif containing proteins have more than one
GPSM motif, and could therefore bind multiple Gα subunits and could conceivably act to
scaffold associated receptors. It has also been reported that GPSM-Gα(GDP) complexes can be
regulated by non-receptor GEFs such as Ric-8A, catalyzing the separation of GPSM motifs from
Gα(GDP) in both GPSM1 and GPSM2, with an apparent preference for myristoylated Gα
subunits (Thomas et al. 2008; Tall & Gilman 2005). It should be noted that while Ric-8A does
bind to GPSM1, it has not always been shown to facilitate Gαi-induced suppression of adenylyl
cyclase and thus may not always act as a GEF in a cellular environment (Tse et al. 2015). RGS7
appears to oppose this process, promoting the reassociation of Gα(GDP) with GPSM-motif
containing proteins (Tall & Gilman 2005).

24
Regulation of GPSM motif function can also occur via the action of other GPSM motifs within
the same protein. These additional motifs can create an ultrasensitivity by acting as competitive
decoys, competing against the activation of the functionally relevant GPSM motif (Lu et al.
2012; Smith & Prehoda 2011). High-affinity decoy sites add a threshold to the response, while
low-affinity decoy sites contribute the ultrasensitive component by ensuring a sigmoidal
response.

1.2.5 CELLULAR FUNCTIONS OF GPSM MOTIF-CONTAINING PROTEINS

Functional studies of GPSM motif-containing proteins indicate their involvement in a wide range
of physiological roles, including cell division, neuronal outgrowth, craving and addiction,
autophagy, and ion channel regulation (Blumer et al. 2007). GPSM1 is upregulated in the
prefrontal cortex of rats during late withdrawal following repeated cocaine exposure (Bowers et
al. 2004). It has therefore been suggested that GPSM1 regulates cocaine-induced behavioral
plasticity via G protein signaling in the prefrontal cortex. GPSM1 has also been linked to early
events in the autophagic pathway in human intestinal HT-29 cells, likely prior to autophagosome
formation (Pattingre et al. 2003). The influence of GPSM motif-containing proteins on G
protein-regulated ion channels has been investigated in both HEK293 cells and X. laevis oocytes
expressing GIRK channels. Full-length GPSM2 and peptides derived from its GPSM motifs
activate basal Gβγ-dependent K+ currents, while siRNA knockdown of GPSM2 decreased basal
K+ currents in primary neuronal cultures (Wiser et al. 2006). Pcp-2 modulated receptor
regulation of Cav2.1 calcium channels expressed in X. laevis oocytes, but had no effect on the
basal current (Kinoshita-Kawada et al. 2004). Complexes between Gαi(GDP) and the GPSM
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regions of GPSM1, Pins, and GPSM2 have been found to regulate both Drosophila and
mammalian asymmetric cell division (ACD). This will be discussed in greater later.

GPSM motif-containing proteins may also play a role in hypertension. Altered Gαi/o mediated
cell signaling has been linked to hypertension; in fact, an increased level of Gαi is one of the
earliest events in animal models of hypertension (Sato & Ishikawa 2010; Anand-Srivastava
1996). In the aorta of 6 week old spontaneously hypertensive (SHR) rats, expression of Gαi was
increased by 40% compared to that in normotensive Wistar-Kyoto (WKY) rats (AnandSrivastava 1992). Uncoupling of GPCRs and Gαi via treatment with pertussis toxin normalizes
the expression of Gαi in SHR rats and results in the reduction of blood pressure to normotensive
levels, delaying the onset of hypertension (Li & Anand-Srivastava 2002; Kost et al. 1999).
GPSM1 null mice exhibit altered blood pressure control mechanisms, including increased
baroreceptor reflex sensitivity and an inability to restore arterial pressure following treatment
with the vasodilating agent sodium nitroprusside (Blumer et al. 2008).

1.3 ASYMMETRIC CELL DIVISION
1.3.1 ASYMMETRIC CELL DIVISION OVERVIEW

Mitotic cell division can be divided into two basic categories: symmetric cell division and
asymmetric cell division. Conventional cell division produces two identical daughter cells,
whereas ACD results in daughter cells with differing fates (Figure 1.7). In ACD, the mother cell
establishes an axis of polarity followed by unequal distribution of cell fate determinants, as well
as unequal orientation of the mitotic spindle along the axis. This involves shifting their division
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Symmetric cell division

Asymmetric
cell division

Figure 1.7. Symmetric versus asymmetric cell division. Symmetric divisions produce two
identical daughter cells. Asymmetric cell division produces daughter cells with differing cell
fates as a result of unequal distribution of fate determinants and resources. Red and green
crescents represent different fate determinants (proteins and RNAs) that can be equally or
unequally partitioned into daughter cells and may differentially influence the developmental
potential of those cells. Adapted from Mapelli & Gonzalez 2012.
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machinery toward a specific region of the cell cortex (Goldstein 2003). Finally, the cell will
asymmetrically divide into two daughter cells (Gönczy 2008). ACD is used by many species to
maintain stem cell populations, as well as during development to generate cellular diversity.
ACD has been well studied in Drosophila melanogaster neuroblasts and Caenorhabditis elegans
embryos, however ACD in mammalian systems remains poorly understood (Willard et al. 2004).

Virtually all of the proteins involved in the process of ACD in lower metazoan models are
evolutionary conserved in mammals (Johnston et al. 2009). D. melanogaster neuroblasts undergo
asymmetric cell divisions to produce a large apical neuroblast and a smaller ganglion mother cell
(GMC) (Willard et al. 2004). The apical determinants Bazooka (partitioning defective protein 3,
PAR-3, in mammals), PAR-6, and aPKC form a protein complex that recruits the Inscuteable
(Insc) protein to the apical cell cortex, directs spindle orientation, and helps segregate the basal
determinants Numb, Miranda, and Prospero. Partner of Inscuteable (Pins, GPSM1 and GPSM2
in mammals) is recruited by Insc to the apical cell cortex, where it then binds Gαi and Mud
(nuclear mitotic apparatus protein, NuMA, in mammals) to form a ternary complex that directs
spindle positioning and contributes to the generation of pulling forces on astral microtubules via
the direct interaction between Mud and the minus-end-directed microtubule motor
Dynein/Dynactin (Mapelli & Gonzalez 2012) (Figure 1.8).

1.3.2 G PROTEINS AND THEIR ACCESSORY PROTEINS IN ASYMMETRIC CELL DIVISION

G proteins are best known for their role in signal transduction downstream of seven
transmembrane receptors, but they also play an essential role in the process of cell division. Gαi2
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Gαi
GPSM2
NuMA
dynein

Figure 1.8. Positioning of the mitotic spindle by GPSM2. The ternary complex (Gαi-GPSM2NuMA), along with dynein/dynactin, positions the mitotic spindle poles in asymmetric cell
division.
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has been reported to bind to the kinetochores of chromatin during mitosis in 3T3 cells (Crouch &
Simson 1997; Crouch et al. 2000). Gαo localizes to the mitotic spindle in a human carcinoma
cell line and multiple animal cell lines, where it co-localizes with β-tubulin (Wu & Lin 1994).
Furthermore, in bovine brain cells, Gβ subunits are incorporated into the mitotic spindle and
interact with the mitotic spindle (Wu et al. 1998).

In gpb-1 (the Gβ homologue) mutant C. elegans embryos, cell division axes are randomly
orientated and centrosome positions are abnormal (Zwaal et al. 1996). Similar results were seen
in neural progenitor cells in the developing mouse neocortex. When the carboxy-terminal region
of β-adrenergic receptor kinase, which is known to sequester free Gβγ without affecting Gα
signaling, was overexpressed, it led to a shift in spindle orientation. When GPSM1 was knocked
down in neural progenitor cells via RNA interference (RNAi), alterations in spindle orientation
similar to that seen with Gβ mutants or knockdowns was observed (Sanada & Tsai 2005). Gβ
and GPSM1 appear to participate in the same processes.

Gα subunits and GPSM2/GPSM1 also appear to participate in similar cell division-related roles.
In C. elegans embryos with RNAi directed against GOA-1 or GPA-16 (Gα homologues),
centrosomes fail to separate properly and incorrect spindle orientations occur as a result of a lack
of centrosome rotation, abnormal centrosome starting positions, and incorrect paths of
centrosome migration (Gotta & Ahringer 2001; Miller & Rand 2000). Simultaneous inactivation
of these Gα subunits results in the almost complete loss of spindle pulling forces from both the
anterior and posterior poles of the dividing cell (Hampoelz & Knoblich 2004). It also results in
the mitotic spindle being centrally instead of asymmetrically located, leading to an equal first
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cleavage rather than the cleavage plane being asymmetrically displaced toward the posterior.
RNAi targeted to GPR-1 and GPR-2, which replace the function of GPSM1 and GPSM2 in C.
elegans, produced similar results (Schneider & Bowerman 2003a; Srinivasan et al. 2003). When
GPB-1 is also inactivated, the result is the same, implying that this is due to the loss of Gα
subunit function and not constitutive activation of Gβγ (Gotta & Ahringer 2001). Overexpression
of Gαi1 in Madin-Darby canine kidney (MDCK) cells, but not Gαs, causes pronounced
oscillations and rotations of the mitotic spindle indicative of strong pulling forces exerted on its
astral microtubules. An identical phenotype is observed with the overexpression of GPSM2 (Du
& Macara 2004).

Numerous studies have implied that the coupling between GPSM motif-containing proteins and
G proteins is important for the proper functioning of the latter during cell division. Gαi proteins
and GPSM motif-containing proteins share similar subcellular localization during mitosis, and
the interaction between GPSM domains and G proteins influences the subcellular localization of
GPSM motif-containing proteins during both interphase and mitosis (Cho & Kehrl 2007; Shu et
al. 2007). Blocking this interaction leads to abnormal exaggerated mitotic spindle rocking in
kidney epithelial cells and cytokinesis defects (Willard et al. 2008; Cho & Kehrl 2007).

The most thoroughly studied GPSM motif-containing protein in the context of cell division is
GPSM2. The expression levels of GPSM2 have been observed to increase during metaphase in
mammalian cell division. Furthermore, subcellular localization studies indicate that GPSM2 is
important for the cortical positioning of the spindle pole, which likely reflects stronger pulling or
pushing forces on the spindle pole (Blumer et al. 2006). Immunocytochemical staining shows
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GPSM2 at the spindle in cells at metaphase, and at the midzone and midbody in cytokinetic cells
(Fukukawa et al. 2010a). A similar pattern of upregulation during mitosis and localization to the
midbody of cytokinetic cells has been reported for Ric-8A (Boularan et al. 2014). GPSM2
transcript levels are upregulated in a large proportion of breast cancers, and treatment of those
cells with siRNA targeting GPSM2 resulted in incomplete cell division and significant growth
suppression in breast cancer cells (Fukukawa et al. 2010a).

In its inactive form, the N-terminus and C-terminus of GPSM2 interact with one another,
precluding the GPSM motifs from interacting with Gαi. However, fluorescent resonance energy
transfer (FRET) studies demonstrate that when it binds the nuclear mitotic apparatus protein
(NuMA), the intramolecular association between the two termini is released and GPSM2 can
bind Gαi (Du & Macara 2004). This anchors the complex to the cell cortex, and the association
between NuMA and the dynein/dynactin structure accounts for this complex’s ability to interact
with microtubules. The motor activity of dynein/dynactin pulls the mitotic spindle to the cell
cortex, thus forming the spindle poles (Merdes et al. 2000) (Figure 1.8).

Precise mitotic spindle orientation is thought to be achieved through cycles of astral microtubule
stabilization and destabilization (Dave et al. 2009). Gαi acts not only as a membrane tether but
also as a switch, allowing ratcheting of pulling forces by rapid cycling of nucleotide exchange
which causes temporary release between components of the Gαi-GPSM2-NuMA complex (Tall
& Gilman 2005). This rapid cycling is accomplished by GAP and GEF activity of accessory
proteins. In C. elegans, RGS7 and Ric-8A fulfill these roles, respectively (Dave et al. 2009).
RGS14, which contains both a GPSM motif and an RGS domain, could in theory act as a GAP in
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addition to binding Gαi making it as attractive candidate for participation in mitotic spindle
orientation (Shu et al. 2007; Cho et al. 2005). GPSM3, which displays GEF activity and an
ability to act as a GDI and bind Gαi, is another attractive prospect for a role in cell division.

1.4 G PROTEIN SIGNALING MODULATOR 3 (GPSM3)
1.4.1 IDENTIFICATION AND CHARACTERIZATION OF GPSM3

GPSM3 is a 160 amino acid protein encoded by a gene within the major histocompatibility
complex class III region of chromosome 6 (Cao et al. 2004; Zhao et al. 2010) (Figure 1.9).
GPSM3 was first discovered in a yeast-based functional screen for activators of the pheromone
response pathway in the absence of a GPCR. The yeast-based system was used to screen a
human prostate leiomyosarcoma cDNA library, and one of the cDNAs isolated in the screen was
GPSM3 (Cao et al. 2004). It contains three GPSM motifs at its C-terminus (conflicting reports
exist regarding the activity of the second GPSM motif), while its short N-terminus contains
multiple proline residues (14 out of 60 amino acids in total) (Kimple et al. 2004; Oner, Maher, et
al. 2010; Zhao et al. 2010). Two different protein isoforms of GPSM3, with different N-terminal
polypeptide sequences, have been predicted in the human genomic sequence database curated by
Ensembl (Billard et al. 2014). The consensus among a number of studies is that GPSM3 is
localized to the cytoplasm in cells, with it sometimes being seen in the nucleus and other times
enriched at the plasma membrane (Cao et al. 2004; Giguère, Laroche, Oestreich, Duncan, et al.
2012; Giguère, Laroche, Oestreich & Siderovski 2012; Zhao & Chidiac 2015). Studies show that
GPSM3 mRNA is detectable in a variety of tissues such as the heart, placenta, lung, liver, brain,
and spleen (Cao et al. 2004; Zhao et al. 2010). However, the public GeneAtlas database of the

1
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1 MEAERPQEEEDGEQGPPQDEEGWPPPNSTTRPWRSA
37 PPSPPPPGTRHTALGPRSASLLSLQTELLLDLVAEAQSR
76 RLEEQRATFYTPQNPSSLAPAPLRPLEDREQLYSTILSH
116 QCQRMEAQRSEPPLPPGGQELLELLLRVQGGGRMEE
153 QRSRPPTHTC
Figure 1.9. Amino acid sequence of GPSM3. The three GPSM motifs are highlighted in
green. The proline-rich N-terminal region is highlighted in red.
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human transcriptome shows that expression is restricted to hematopoietic cells with the highest
signal strength in whole blood and CD14+ monocytes (Giguère et al. 2013). GPSM3 expression
is also seen in rat epithelial cells and vascular smooth muscle cells (Zhao & Chidiac 2015).

The list of protein-protein interactions that GPSM3 participates in has grown steadily in the
literature over the past few years, with many partners being associated with G protein signaling
(Table 1.2). GPSM3 has been shown to bind members of the Gαi/o family, coupling with Gαo
and all three isoforms of Gαi (Cao et al. 2004). It shows a strong preference for Gαi over Gαo.
GPSM3 does not interact with Gαs, Gαq, or Gα16. A study has shown that GPSM3 also
associates with the first four isoforms of Gβ, however it apparently does not interact with Gβγ
(Giguère, Laroche, Oestreich & Siderovski 2012; Cao et al. 2004). RGS5 has been identified as
an interaction partner of GPSM3 (Zhao & Chidiac 2015), and BRET signals between GPSM3
and the α2 adrenergic receptor have been observed as well (Oner, Maher, et al. 2010). GPSM3
appears to form a complex with NOD-like receptor family, pyrin domain containing 3 protein
(NLRP3) and the heat shock A8 protein (HSPA8) (Giguère et al. 2014). The 14-3-3 family of
proteins stabilize GPSM3, and up to 25 potentially regulatory phosphorylation sites have been
identified in GPSM3 (Giguère, Laroche, Oestreich, Duncan, et al. 2012; Bian et al. 2014).

1.4.2 FUNCTIONAL ROLES OF GPSM3

GPSM3 was discovered in a yeast-based screen that required Gβγ activation to single out
activating proteins, and the GPSM motif is capable of promoting the dissociation of heterotrimer
subunits (Cao et al. 2004; Ghosh et al. 2003). This would be expected to lead to the activation of
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Table 1.2. GPSM3 protein-protein interaction partners.
Protein

Reference

Confirmed via interaction study
Gαi1-3

(Cao et al. 2004; Zhao et al. 2010)

Gαo

(Cao et al. 2004; Zhao et al. 2010)

Gβ1-4

(Giguère, Laroche, Oestreich & Siderovski
2012)

14-3-3 family members

(Giguère, Laroche, Oestreich, Duncan, et al.
2012)

NOD-like receptor family, pyrin
domain containing 3 protein (NLRP3)

(Giguère et al. 2014)

Heat shock protein A8 (HSPA8)

(Giguère et al. 2014)

α2 adrenergic receptor

(Oner, Maher, et al. 2010)

RGS5

(Zhao & Chidiac 2015)

Experimental evidence
Fibroblast growth factor 3 (FGFR3)

(Lehner et al. 2004)

Supervillin (SVIL)

(Nebl et al. 2002)
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PLCβ, however one study showed that overexpression of GPSM3 fails to appreciably increase
inositol phosphate levels and another showed that it in fact resulted in a decrease in inositol
phosphate levels by greater than 50% (Cao et al. 2004; Giguère, Laroche, Oestreich &
Siderovski 2012). This suggests that GPSM3 does not promote Gβγ-mediated cell signaling via
the promotion of heterotrimer dissociation. When expressed in the presence of membranetethered or GPCR-tethered Gαi1/2, GPSM3 is apparently redistributed to the plasma membrane
(Willard et al. 2008; Robichaux et al. 2015; Oner, Maher, et al. 2010). Gαi/o mutants incapable
of binding to GPSM motifs did not exhibit this effect (Willard et al. 2008). Agonist activation of
the α2A adrenergic receptor leads to decreased BRET signals between Gαi2 and GPSM3. This
suggests that seven transmembrane receptors can bind Gαi-GPSM3 complexes and that receptor
activation leads to reversible dissociation between GPSM3 and Gαi in a cycle analogous to that
seen with receptor and Gαβγ (Robichaux et al. 2015). GPSM3 also appears to be regulated by the
non-receptor GEFs, with the interaction between GPSM3 and Gαi1 being regulated in a biphasic
manner by Ric-8A depending on its level of expression. However, the increasing BRET signal at
high Ric-8A concentrations is likely due to the observation that Ric-8A increases Gαi1
expression levels (Oner et al. 2013).

As expected, GPSM3 demonstrates G protein regulatory effects on Gα subunits. The three
GPSM motifs in its C-terminal region display GDI activity for Gαi/o subunits (Cao et al. 2004;
Zhao et al. 2010; Oner, Maher, et al. 2010). Whether all three of these GPSM motifs can bind
Gαi/o subunits at the same time remains to be seen, however reports on GPSM motifs suggest
that additional motifs may act as competitive decoys in order to create one ultrasensitive
functional motif (Lu et al. 2012; Smith & Prehoda 2011). The proline-rich N-terminal domain of
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GPSM3 exhibits the unique ability to differentially affect the nucleotide state of different Gα
subunits, which is not surprising since repetitive proline-rich sequences are often found to be
docking sites for signaling modules (Zhao et al. 2010; Cao et al. 2004). The N-terminal region of
GPSM3 displays weak GDI effects on Gαo, but interestingly it exhibits GEF activity on Gαi1
(Zhao et al. 2010). It has also been shown that GPSM3 enhances the GAP activity of RGS5 by
binding to it, and that this binding in turn impedes the inhibitory effect of GPSM3 on GTP
turnover (Zhao & Chidiac 2015). GPSM3 may also regulate the stability of Gβ subunits before
they become complexed with Gγ (Giguère, Laroche, Oestreich & Siderovski 2012).

1.4.3 GPSM3 DISEASE ASSOCIATION

GPSM3 has been linked to a large number and variety of diseases. Significant increases in the
expression of GPSM3 are observed in a rat model for polycystic kidney disease compared to the
non-cystic controls (Lenarczyk et al. 2015). In prostate cancer models which mimic
angiogenesis, GPSM3 expression increases by greater than two-fold relative to controls, and it
has been identified as a gene required for the proliferation of p53 human cancer cell lines (Lapan
et al. 2009; Xie et al. 2012). Expression changes in GPSM3 have also been connected to cell
culture adaptation (Tompkins et al. 2012). GPSM3 polymorphisms are associated with childhood
obesity in Hispanic populations and atopic dermatitis (Comuzzie et al. 2012; Chang et al. 2012).
The connection between GPSM3 and autoimmune disease has been well established, with links
to ulcerative colitis, systemic lupus, rheumatoid arthritis, and ankylosing spondylitis (Pathan et
al. 2009; Barcellos et al. 2009; Giguère et al. 2013).
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The first connection between GPSM3 and arthritis was discovered when polymorphisms within
the human GPSM3 gene locus were identified as being significantly less prevalent in multiple
autoimmune diseases (Sirota et al. 2009; Corona et al. 2010). These protective genetic variants
have been found to result in a decrease in GPSM3 transcript abundance in individuals
homozygous for the single nucleotide polymorphisms (Gall, Wilson, et al. 2016). The effects of
GPSM3 on myeloid-dependent autoimmune disease have been studied in a GPSM3-/- mouse
model in which collagen antibody-induced arthritis (CAIA) was induced (Giguère et al. 2013).
Mice lacking GPSM3 were protected from CAIA, showing significant decreases in paw swelling
and clinical disease scores, as well as a reduction in inflammation and cartilage erosion
compared to controls. Furthermore, monocyte-representative pro-inflammatory cytokines and
chemokine receptors were decreased in GPSM3-/- mouse paws, and GPSM3-deficient myeloid
cells had reduced migration.

GPSM3 mRNA and protein levels are both seen to decrease when the monocytic THP-1 cell line
is differentiated into macrophage-like cells, suggesting a role in both differentiation and
migration of monocytes. Knockdown of GPSM3 in this cell line disrupts ex vivo migration
towards certain chemokines (Gall, Wilson, et al. 2016). In the human promyelocytic leukemia
NB4 cell line, GPSM3 transcript and protein levels increase in response to retinoic acid-induced
differentiation into a model of neutrophil physiology (NB4*). Reducing GPSM3 expression in
NB4* cells using siRNA disrupts chemotaxis towards chemoattractants involved in neutrophil
recruitment to the arthritic joint (Gall, Schroer, et al. 2016). Interleukin-1β, triggered by NLRP3dependent inflammasome activators, is negatively regulated by GPSM3 (Giguère et al. 2014).
GPSM3-null mice have enhanced serum and peritoneal interleukin-1β production following
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intraperitoneal aluminum hydroxide injection, and bone marrow-derived macrophages lacking
GPSM3 expression show a significant increase in NLRP3-dependent IL-1β secretion (Giguère et
al. 2014).

1.4.4 GPSM3 IN VASCULAR SMOOTH MUSCLE CELLS

Vascular smooth muscle cells (VSMCs) typically have a contractile phenotype that allows the
smooth muscle comprised of them to expand and contract, thereby controlling the diameter of
the vasculature. However, the transition of VSMCs from a contractile to a migratory,
proliferative phenotype is known to underlie cardiovascular disease and also occurs in response
to isolation and culturing (Sandison et al. 2016; Dzau et al. 2002; Fingerle et al. 1989). Other
GPSM motif-containing proteins such as GPSM2 and GPSM1 have been implicated in both cell
migration (Taymans et al. 2006; Kamakura et al. 2013) and proliferation, while GPSM3 has
previously been linked with cell migration (Giguère et al. 2013; Gall et al. 2016). Therefore,
vascular smooth muscle cells, which are known to express GPSM3, are an excellent model to
study a potential role for GPSM3 in cell division (Zhao & Chidiac 2015). In this study, VSMCs,
in addition to other tissues, were obtained from Wistar-Kyoto rats (WKY) and spontaneously
hypertensive rats (SHR). SHR rats display significantly higher blood pressure than their WKY
counterparts (approximately 193 mmHg compared to approximately 133 mmHg) (Leung et al.
2016). In addition to elevated blood pressure, these rats have many other differences with
normotensive WKY rats including increased Gαi-mediated pathway activity likely contributing
to hypertension, increased innervation in the spleen and thymus, and increased inflammation of
the liver, heart, kidney, and brain (Kost et al. 1999; Purcell & Gattone 1992; Sun et al. 2006).
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SHR vascular smooth muscle cells have been shown to divide at a rate 1.75 times that of WKY
VSMCs (Hadrava et al. 1991). This increased proliferation rate could be linked to the
hypertensive phenotype in SHR rats as division of VSMCs could increase blood vessel wall
thickness and in the process decrease the diameter of the vessel. Additionally, a difference in
GPSM3 protein expression in VSMCs was seen in our lab, with VSMCs derived from SHR rats
exhibiting greater expression than WKY-derived VSMCs (Zhao 2011). Elevated expression of
GPSM3 could be linked to the increased rate of proliferation in VSMCs and the hypertensive
phenotype of SHR rats.

1.5 RESEARCH PURPOSE AND AIMS

The fundamental participants of GPCR-mediated cell signaling were originally recognized to be
the receptors, heterotrimeric G proteins, and effectors. However, over time, studies have begun
to reveal that signaling processes are not as simple as once imagined. Accessory proteins such as
GPSM3 fine-tune signals by influencing the nucleotide-state of the Gα subunit, and may
participate in non-canonical G protein signaling via alternative complexes. They also perform
other cellular functions, such as their role in asymmetric cell division. However, GPSM3 has not
been linked to cell division in the literature at this time. The purpose of this study is to
investigate whether or not GPSM3 plays such a role. I hypothesize that G protein signaling
modulator 3 plays a role in cell division of mammalian cells, likely via an interaction with the
mitotic spindle. This role in mammalian cells is investigated in a vascular smooth muscle cell
model system. The specific aims of this study are:

41
1. To investigate the difference in GPSM3 transcript and protein levels between
normotensive Wistar-Kyoto rats and spontaneously hypertensive rats.
2. To investigate whether GPSM3 expression is linked to the rate of cell division.
3. To investigate potential mechanisms of action for GPSM3 in the process of cell
division via its interaction with other proteins and its localization during mitosis.
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2 METHODS
2.1 TISSUE SAMPLE COLLECTION

Dr. Robert Gross performed all tissue sample collection. All animal work was carried out in
accordance with official guidelines. Four male Wistar-Kyoto (WKY) and four male
spontaneously hypertensive (SHR) rats (Harlan Laboratories, Indianapolis, IL) were sacrificed at
10 weeks of age, after the onset of hypertension in the SHR rats. Rats were anaesthetized with
3% isofluorane gas, then sacrificed by cardiac puncture and whole blood was collected. Tissue
samples from the aorta, heart, liver, lung, and spleen were collected. Leukocytes were isolated
from heparin-treated whole blood using a ficoll-hypaque solution and differential centrifugation
according to the method of Böyum 1968. All samples were stored at –80˚C.

2.2 AORTIC VASCULAR SMOOTH MUSCLE CELL ISOLATION
Vascular smooth muscle cells (VSMCs) were kindly provided by Dr. Robert Gros. All animal
work was carried out in accordance with official guidelines. A modified version of the protocol
from Cornwell & Lincoln 1989 was used to isolate the VSMCs. Male WKY and SHR rats at 10
weeks of age were used, after the onset of hypertension in the SHR rats. Rat aortas were cleaned
and cut longitudinally. Adipose tissue was removed via enzymatic digestion by placing aortas in
1 ml of Ham’s F12 medium (ThermoFisher Scientific, Waltham, MA, with 1% gentamycin and
10% fetal bovine serum, FBS) and 1 mg of collagenase per aorta and incubating for 20 minutes
at 37°C. Medium was removed. 1 ml of Ham’s F12 medium and 1 mg of collagenase per aorta
were added and sample was incubated for 30 minutes at 37°C, followed by removal of the
medium and a further, identical incubation in fresh medium supplemented with collagenase.
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Samples were centrifuged for 5 minutes at 200 x g at room temperature. The supernatant was
then discarded. The pellet was resuspended in 1 ml of Ham’s F12 medium, and 1 mg
collagenase, and 0.5 mg elastase per aorta and incubated for 90 minutes at 37°C. Sample was
collected by pipette and filtered using a Nitex 100 µm cell strainer to dissociate clumps into a
uniform single-cell suspension. 10 ml Dulbecco’s Modified Eagle Medium (DMEM, Gibco Life
Technologies, Carlsbad, CA) (with 10% FBS) was then added to the filtrate. The cell suspension
was then centrifuged for 5 minutes at 200 x g at room temperature. Supernatant was collected
and discarded. Cells were resuspended in 10 ml DMEM (with 10% FBS and 10%
fungizone/gentamicin), and then plated in a 10 cm cell culture dish.

2.3 SERUM STARVATION AND REPLACEMENT
2.3.1 SERUM STARVATION AND REPLACEMENT PRIOR TO RNA AND PROTEIN
EXTRACTION

WKY and SHR vascular smooth muscle cells were grown in DMEM (with 10% FBS) at 37˚C.
When cells were 60% confluent, medium was removed and cells were washed in 1X sterile
phosphate-buffered saline (PBS, Fisher Scientific) (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, pH 7.4). DMEM (with 0% FBS) was then added and cells were incubated for 48 hours
at 37˚C. Medium was then removed, cells were washed in sterile PBS again, and DMEM (with
10% FBS) was added. Cells were grown for an additional 48 hours at 37˚C. Cells were collected
and processed for either RNA extraction or protein extraction at 24 hour intervals during the
course of the experiment.
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2.3.2 SERUM STARVATION AND REPLACEMENT PRIOR TO IMMUNOFLUORESCENT
LABELING

WKY and SHR vascular smooth muscle cells were grown in DMEM (with 10% FBS) at 37˚C.
When cells were 40% confluent, medium was removed and cells were washed in sterile
phosphate buffered saline (PBS). DMEM (with 0% FBS) was then added and cells were
incubated for 24 hours at 37˚C. Medium was then removed, cells were washed in sterile PBS
again, and DMEM (with 10% FBS) was added. SHR VSMCS were grown for an additional 12
hours at 37˚C while WKY VSMCs were grown for an additional 20 hours at 37˚C. Cells were
then prepared for immunofluorescent labeling and imaging.

2.4 RNA EXTRACTION

Total RNA was extracted from both cell culture and homogenized tissue samples using TRIzol
reagent (Invitrogen, Carlsbad, CA). Samples were incubated in TRIzol reagent at room
temperature for 5 minutes. 200 µl of chloroform per 1 ml of TRIzol reagent was added and
samples were vortexed for 15 seconds. Samples were incubated at room temperature for 3 min,
following which they were centrifuged at 4˚C for 15 minutes at 5300 x g. The aqueous phase was
extracted, and 500 µl of isopropanol per 1 ml TRIzol reagent used was added to precipitate RNA.
Samples were incubated at room temperature for 10 minutes, and then centrifuged at 4˚C at 5300
x g for 20 minutes. Supernatant was removed and pellets were superficially washed with 1 ml
75% ethanol per 1 ml TRIzol reagent used. Samples were centrifuged at 4˚C at 5300 x g for 10
minutes. The supernatant was removed, and pellets allowed to air dry. Dry pellets were stored at
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–80˚C, and later suspended in DEPC water (Life Technologies) and diluted to 0.05 µg/µl. RNA
purity and concentrations were quantified through spectrophotometry (NanoDrop Lite, Thermo
Scientific). RNA samples with an absorbance ratio (A260 nm / A280 nm) of 1.8-2.2 were determined
to be sufficiently pure for use in PCR applications.

2.5 REVERSE TRANSCRIPTION (RT-PCR) AND QUANTITATIVE POLYMERASE CHAIN
REACTION (QPCR)

RNA samples (2 µg) were reverse transcribed (RT-PCR) to generate first strand cDNA using a
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) on a T100 Thermo Cycler
(BioRad). Primer sets directed against target genes of interest were designed using the National
Centre

for

Biotechnology

Information

Nucleotide

sequences

database

(www.ncbi.nlm.gov/nuccore) and Invitrogen’s OligoPerfect Designer primer designing tool
(www.thermofisher.com/oligoperfect/). Primers were custom manufactured by and purchased
from Sigma-Aldrich (St. Louis, MO) Custom DNA Oligos (Table 2.1). mRNA expression levels
of GPSM3 were determined through qPCR carried out in 384 well plates using fluorescent
nucleic acid dye SensiFAST SYBR Green No-ROX kit (Bioline) based assays, following the
manufacturer’s protocol. Reactions were carried out on CFX384 Real Time PCR Detection
System and analyzed using a CFX Manager 3.0 program (BioRad). The cycle threshold was set
so that exponential increases in amplification were approximately level between all samples at
the linear phase of the amplification curves. Relative mRNA levels of rGPSM3 were generated
from five-fold serial dilutions of pooled cDNA samples, and then normalized to a reference gene
(GAPDH in tissue samples and β2-microglobulin in VSMC primary culture samples). Reference
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Table 2.1. Primers for qPCR
Target gene

Forward Primer

Reverse Primer

GPSM3

5’-CCTTCTCTCTGGGACTCAAA-3’

5’- AGCCCTCACAACCTGTTTAG-3’

GAPDH

5’-AACTTTGTGAAGCTCATTTCCT-3’

5’-ATTGATGGTATTCGAGAGAAGG-3’

5’- ACGTTTGTCTTGGTGATGTG-3’

5’-CAGTAGTCCCTGATGCTCCT-3’

B2M (β2microglobulin)
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genes were stable across all samples and conditions to allow comparative assessments on the
relative change in the expression of GPSM3.

2.6 PROTEIN ISOLATION

Cell lysates were prepared by washing twice with ice-cold 1X phosphate-buffered saline (PBS,
Fisher Scientific) (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, pH 7.4) and scraped into 150
µl of ice-cold lysis buffer (250 mM NaCl, 50 mM Tris pH 8, 5 mM EDTA, 0.5% Triton X-100
(IGEPAL), phenylmethylsulfonyl fluoride protease inhibitor tablet (Roche, 04693116001), 20
mM Na4P2O7, 10 mM NaF, and 20 mM Na3VO4). Cell lysates were homogenized by vigorous
pipetting and underwent three consecutive freeze-thaw cycles via flash freezing with liquid
nitrogen. Pellets were sedimented by centrifugation at 11,000 x g for 15 minutes at 4ºC.
Supernatants were collected and protein concentrations were determined using a Bicinchoninic
Acid Protein Assay Kit (Sigma, BCA1) and a VICTOR3V Microplate Reader (PerkinElmer,
1420-251).

2.7 IMMUNOBLOTTING

Protein samples were prepared in 5X Laemmli loading (sample) buffer (60 mM Tris-HCl pH 6.8,
2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.02% bromophenol blue) and balanced with 1X
sample buffer for equal protein concentration. Samples were heated at 99ºC for 5 minutes prior
to gel loading and gel electrophoresis in order to denature the proteins. Equal amounts of protein
(30 µg) were separated by 15% SDS-PAGE and wet transferred onto nitrocellulose membrane
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(Whatman Protran). Membranes were incubated for 1 hour in blocking buffer (Tris-buffered
saline, 0.1% Tween 20, 5% skim milk) and rocked at room temperature before overnight
incubation at 4ºC, rocking with either: anti-GPSM3 (1:500, GeneScript custom ordered,
described in Zhao & Chidiac 2015) or anti-β tubulin for protein loading control (1:1000, Pierce
PA5-16863). Following overnight incubation, membranes were washed 4 times for 5 min with
TBST (Tris-buffered saline, 0.1% Tween 20) and incubated for 1 h at room temperature with
horseradish peroxidase-conjugated secondary antibodies: anti-rabbit IgG (1:4000, Pierce 31463).
Immunoblots were then washed 4 times for 5 min with TBST. Immunoblots were visualized with
SuperSignal West Pico chemiluminescent substrate (ThermoFisher Scientific, 34080) and
digitally imaged using Bio-Rad VersaDoc camera and Quantity One program (Bio-Rad, model
GS-700). Relative protein expression levels from immunoblots were quantified and analyzed
using densitometry software (Quantity One, Bio-Rad). Relative densitometric signal of protein
bands were determined with subtraction of background signal of immunoblots, and GPSM3
protein bands were then normalized to corresponding β-tubulin bands.

2.8 TRANSFECTION

All transfections were performed using the Human Embryonic Kidney 293 (HEK-293) cell line
under standard conditions of 37ºC and 5% CO2, in DMEM with 10% FBS. HEK-293 cells are
commonly used for in vitro experiments due to their ease of transient transfection (Li et al.
2013).
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2.8.1 TRANSFECTION FOR MTT ASSAY AND CELL COUNTING

Plasmid constructs encoding EYFP (enhanced yellow fluorescent protein)-tagged GPSM3 were
generously donated by Dr. Joe Blumer from the Medical University of South Carolina and are
described in Oner et al. 2010. To summarize the protocol, cells were seeded and grown to 7085% confluence in a 100 mm dish before transfection. Once 70-85% confluent, 400 ng of EYFP
or EYFP-GPSM3 DNA plasmid was diluted in 450 µl of sterilized water in a sterile tube. 50 µl
of 2.5 M CaCl2 was added to the diluted DNA, followed by 500 µl of 2x HEPES-buffered saline
(HBS) solution (0.28 M NaCl, 0.05 M HEPES, 1.5 mM Na2HPO4, pH 7.0) that was slowly
dripped over the DNA/CaCl2 solution and then mixed immediately. The mixture was then slowly
dripped over the cells which were incubated for ~18 hours with the transfection reagents.
Following incubation, cells were washed with 1x PBS three times and fresh DMEM with 10%
FBS was added. Cells were allowed to recover from transfection for 3-6 hours and then diluted 1
in 12.5 in addition fresh DMEM with 10% FBS. Cells were then reseeded in 24-well plates with
500 µl per well.

2.8.2 TRANSFECTION FOR MAMMALIAN TWO-HYBRID ASSAY

Transfections were performed using Lipofectamine 2000 (Life Technologies, 11668-019)
according to the manufacturer’s protocol. To summarize the protocol, cells were seeded and
grown to 70% confluence before transfection. Once 70% confluent, 10 µl of Lipofectamine 2000
reagent was diluted into 250 µl of Opti-MEM® I Reduced Serum Medium (Life Technologies,
31985-070) in an Eppendorf tube. In a separate eppendorf tube, 1 µg of each plasmid DNA to be
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transfected was diluted in 250 µl of Opti-MEM® I Reduced Serum Medium and both eppendorf
tubes were incubated at room temperature for 5 minutes. The contents of the eppendorf tubes
were thoroughly mixed together and were incubated at room temperature for 20 minutes. The
combined mixture was added to the cells and the cells were plated in a 96-well clear bottom
white assay plate. The mixture was allowed to incorporate into the cells for 24 hours.

2.9 MTT ASSAY

An MTT assay measures time-related changes in the metabolic activity of cells via their ability
to reduce MTT reagent (tetrazolium salts) into formazan crystals. The purple formazan crystals
can then be solubilized in DMSO and quantified by spectrophotometry. This can be used as a
proxy for measuring the proliferation rate of cells. Transfected cells were subjected to an MTT
assay on each of the five days of the experiment in order to assess changes in cell population,
with the first day being marked as day 0. Separate wells were used for each day as MTT reagent
is cytotoxic and the cells can be damaged and even killed during the course of the MTT assay
(Riss 2006). A nonlinear regression was performed on both data sets using a exponential plateau
model with the equation Y = Y0 + (Ymax – Y0)*(1 – e^(-k*x)), where Y0 is the Y-intercept, Ymax
is the plateau value, e is Euler’s number, k is the growth rate constant measured in reciprocal
units to those x is measured in (days-1), x is time in days, and Y is the absorbance value
representing cell population size. Doubling time (DT) can then be calculated as DT = ln2 / k.

50 µl of 2.5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT reagent,
Sigma M2128) was added to each well in a 24-well plate and incubated at 37°C for 2 hours.
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Following incubation, medium was slowly aspirated so as to not disrupt the formazan crystals.
500 µl of working grade dimethyl sulfoxide (DMSO) was added to each well and the plate was
covered in aluminum foil. Plates were rocked for 2 hours and then absorbance was measured
using a wavelength of 595 nm on a Thermo Multiskan Spectrum 1500 spectrophotometer
(ThermoFisher Scientific, 51118750). Three control wells per plate containing only 500 µl of
DMSO are also measured and the average value of these was subtracted from the experimental
values.

2.10 CELL COUNT ASSAY

To ensure that the MTT data was indicative of an increased rate of proliferation and not
increased cell size resulting in increased metabolism, cell counts were performed on cells
expressing EYFP or EYFP-GPSM3. Five locations chosen at random within each well were
imaged using an Olympus IX71 fluorescent microscope (Olympus Canada) and the number of
cells expressing EYFP or EYFP-GPSM3 was analyzed using ImageJ software.

2.11 IMMUNOFLUORESCENT LABELING

Adherent cells were washed once in 1 ml 37°C PBS. Cells are then fixed by incubation in 1 ml
4% formaldehyde for 10 minutes at room temperature and then washed five times with 1 ml
room temperature PBS. Cells were then incubated in 1 ml 0.25% triton X-100 (in PBS) for 5
minutes at room temperature and then washed five times with 1 ml room temperature PBS. Cells
were incubated in 1 ml room temperature PBS containing 10% FBS for 1 hour. Next, cells were
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incubated in 1 ml anti-GPSM3 primary antibody and anti-β-tubulin primary antibody (diluted
1:500 in PBS) overnight at 4°C. Cells were then washed fives times with 1 ml room temperature
PBS and then incubated in 1 ml AlexaFluor 488 goat anti-rabbit and AlexaFluor 568 goat antimouse secondary antibodies (diluted 1:500 in PBS) for 1 hour at room temperature in the dark.
Cells were then washed five times in 1 ml room temperature PBS. Cells are next incubated in
250 µl DAPI (ThermoFisher Scientific, 62248) (diluted 1:1000 in PBS) for 5 minutes at room
temperature and then washed three times with 1 ml room temperature PBS. Finally, cells are
immunomounted by applying a small drop of medium to a glass slide and placing the cell-coated
coverslip face down onto the droplet. The slide is stored in the dark for at least 2 hours until dry.
Cells are then visualized on an Olympus FV1000 confocal microscope at the Robarts Research
Institute’s Confocal Microscopy Core Facility. 10 µg/µl anti-GPSM3 primary antibody blocking
peptide (GenScript) was added to the 1 ml PBS containing anti-GPSM3 primary antibody and
anti-β-tubulin primary antibody (diluted 1:500) and incubated overnight at 4°C for the blocking
peptide experiments. The blocking peptide sequence, EAERPQEEEDGEQC, corresponds to the
first fourteen amino acids of GPSM3 following the initial methionine.

2.12 MAMMALIAN TWO-HYBRID SYSTEM

The CheckmateTM Mammalian Two-Hybrid System (Promega, E2440) enables in vivo detection
of protein-protein interactions. This is accomplished using three vectors: pACT, pBIND, and
pG5luc (Figure 2.1). Both the pACT and pBIND vectors utilize a human cytomegalovirus
(CMV) immediate early promoter to drive expression. In addition, the pBIND vector expresses
the Renilla reniformis luciferase under the control of the SV40 promoter, which allows for
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Figure 2.1. CheckmateTM Mammalian Two-Hybrid System vectors.
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normalization of differences in transfection efficiency. The pG5luc vector contains five GAL4
binding sites upstream of a minimal TATA box, which in turn is upstream of the firefly
luciferase gene. Subcloning a target gene into the pACT vector and subsequent expression results
in the protein of interest with a C-terminally attached transcriptional activation domain.
Subcloning a target gene into the pBIND vector and subsequent expression results in the protein
of interest with a C-terminally attached DNA-binding domain. When a gene of interest with an
attached transcriptional activation domain interacts with a second gene of interest with an
attached DNA-binding domain, these two attached domains become closely associated. This
results in the promotion of the assembly of RNA polymerase II complexes at the TATA box of
the pG5luc vector, which increases transcription of the firefly luciferase reporter gene. Each gene
of interest is subcloned into both the pACT and pBIND vectors. This is done to overcome the
phenomenon of vector directionality, which is the apparent difference in strength of observed
interactions depending on the vector context of each insert. Therefore, each protein-protein
interaction is tested with both possible fusion protein interactions. The kit also provides positive
control vectors: pACT-MyoD and pBIND-Id. A negative control consists of pACT and pBIND
without inserts. See Table 2.2 for a list of genes of interest.

2.13 DNA CONSTRUCTS

Plasmids encoding the genes of interest were subjected to PCR using Platinum® Pfx DNA
polymerase (ThermoFisher Scientific, 11708021) as per the manufacturer’s instructions and
primers (Table 2.3) designed to introduce highly specific nucleotide sequences (restriction sites)
on either side of the gene. PCR products were run on a 1% agarose gel (0.011 g/ml UltraPureTM
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Agarose (Invitrogen), 40 mM Tris-acetate, 1 mM EDTA, 0.02 µl/ml ethidium bromide, pH 8.3)
for 45-120 minutes at 100-150 V. DNA bands were viewed on gel under UV light, excised, and
then purified using a Gel/PCR DNA Extraction Kit (FroggaBio, Toronto, ON, DF100) as per the
manufacturer’s instructions. Genes of interest that were considered too long for the PCR method
to be reliable were altered using gBlocksTM designed by Dr. Alexey Pereverzev to have the
necessary restriction sites (synthesized using the Gibson Assembly™ method based on the
technique described by Gibson et al. 2009). Plasmids encoding both the genes of interest as well
as the parent vectors were then digested with the appropriate restriction enzymes (Table 2.2) as
per the manufacturer’s instructions. The digested fragments of DNA were separated on 1%
agarose gel (0.011 g/ml UltraPureTM Agarose (Invitrogen), 40 mM Tris-acetate, 1 mM EDTA,
0.02 µl/ml ethidium bromide, pH 8.3) for 45-120 minutes at 100-150 V. DNA bands were
viewed on gel under UV light, excised, and then purified using a GenepHlowTM Gel/PCR Kit
(FroggaBio, DFH100) as per the manufacturer’s instructions. Each digested gene of interest was
then ligated into both parent vectors using T4 DNA Ligase (Promega, M1801). The products of
these ligations were then transformed into Subcloning EfficiencyTM DH5αTM Competent Cells
(ThermoFisher Scientific, 18265017) as per manufacturer’s instructions and plated on an agar
plate containing 100 µg/ml ampicillin and incubated overnight at 37°C. Bacterial colonies were
chosen and grown in selective medium overnight at 37°C and at 225 RPM. Plasmid was then
purified using PrestoTM Mini Plasmid Kit (FroggaBio, PDH300) as per manufacturer’s
instructions. The Robarts Research Institute DNA Sequencing Facility (London, ON) confirmed
all DNA sequences via fluorescent DNA sequencing.
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Table 2.2. Genes of interest and the restriction enzymes used for subcloning.
Gene
GPSM3

GPSM3-mGL

GNAI1 (Gαi1)
GNAI2 (Gαi2)
GNAS (Gαs)
GNAO (Gαo)
GNAO (Gαo-Q205L)
GNB1 (Gβ1)
FGFR3
SELPLG

Company (plasmid)
Kindly provided by Dr. David
P. Siderovski, Department of
Physiology and
Pharmacology, West Virginia
University School of
Medicine, Morgantown, WV,
USA
cDNA Resource Center,
GNAI10EI00
cDNA Resource Center,
GNAI20EI00
cDNA Resource Center,
GNA0SSEI00
cDNA Resource Center,
GNA0OAEI00
cDNA Resource Center,
GNA0OA00C0
cDNA Resource Center,
GNB0100000
DNASU Plasmid Repository,
HsCD00294949
DNASU Plasmid Repository,
HsCD00041063

NUMA1 (NuMA)

Addgene, Plasmid #28238

NIN (Ninein)

DNASU Plasmid Repository,
HsCD00516498

SVIL (Supervillin)

Addgene, Plasmid #13040

Restriction enzymes
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
XbaI (Fermentas, FD0684)
SalI (Invitrogen, 15217-029),
MluI (Roche, 10663721)
KflI (ThermoFisher Scientific,
FD2164), SpeI (NEB,
R0133S), SalI (Invitrogen,
15217-029), NotI (NEB,
R0189S)
SalI (Invitrogen, 15217-029),
MluI (Roche, 10663721)
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Table 2.3. Primers for Mammalian Two-Hybrid experiments.

Target

Forward Primer

Reverse Primer

GPSM3, GPSM3mGL

5’-ACGCGTCGACCCATGGAGGCT
GAGAGACCCCAGGAAGAAGAG-3’

5’- GCTCTAGATCAGCAGGTGT
GTGTGGGGGGCCGGGACCT-3’

5’-ACGCGTCGACCCATGGGCTGC
ACGCTGAGCGCCGAGGACAAG-3’

5’-CGAGGCTGATCAGCGGGTTTA
AACGGGCCCTCTAGACTCGAG-3’

5’- ACGCGTCGACCCATGGGCTGC
CTCGGGAACAGTAAGACCGAG-3’

5’-CGAGGCTGATCAGCGGGTTTA
AACGGGCCCTCTAGACTCGAG-3’

5’-ACGCGTCGACCCATGGGATGT
ACTCTGAGCGCAGAGGAGAGA-3’

5’-GCTCTAGATCAGTACAAG
CCGCAGCCCCGGAGGTTGTT-3’

GNB1 (Gβ1)

5’-ACGCGTCGACCCATGAGTGA
GCTTGACCAGTTACGGCAGGAG-3’

5’-GCTCTAGATTAGTTCCAG
ATCTTGAGGAAGCTATCCCA-3’

FGFR3

5’-ACGCGTCGACCCATGGGCGCC
CCTGCCTGCGCCCTCGCGCTC-3’

5’-GCTCTAGACTACGTCCGC
GAGCCCCCACTGCTGGGTGG-3’

SELPLG

5’-ACGCGTCGACCCATGCCTCT
GCAACTCCTCCTGTTGCTGATC-3’

5’-GCTCTAGACTAAGGGAGG
AAGCTGTGCAGGGTGAGGTC-3’

GNAI1/2 (Gαi1,
Gαi2)

GNAS (Gαs)

GNAO (Gαo, GαoQ205L)

58
2.14 LUCIFERASE ASSAY SYSTEM

The Dual-Glo® Luciferase Assay System (Promega, E2920) was utilized to quantify luciferase
reporter gene expression as a measure of the strength of tested protein-protein interactions, as per
manufacturer’s instructions. Briefly, a volume of Dual-Glo® Reagent equal to the volume of
culture medium in the well was added to each well, mixed, and allowed to sit for 10 minutes
while cell lysis occurred. Firefly luciferase luminescence was then measured using a VICTOR3V
Microplate Reader (PerkinElmer, 1420-251). To quench this reaction, a volume of Dual-Glo®
Stop & Glo® Reagent equal to the original culture medium volume was then added to each well,
mixed, and allowed to incubate for 10 minutes at room temperature. Renilla luminescence was
then measured. Wells were measured in the same order on each plate when measuring Firefly
and Renilla luminescence. Nontransfected cells were used to assess background luminescence
(for both Firefly and Renilla luciferase) and this background was subtracted from all
luminescence readings. Firefly luciferase luminescence was then normalized to Renilla
luminescence to account for differences in transfection efficiency. Finally, a relative response
ratio (RRR) is then calculated in order to evaluate the results in the context of the positive and
negative controls, using the following equation:

RRR =

experimental sample ratio − negative control ratio
positive control ratio − negative control ratio

59
2.15 STATISTICAL ANALYSES

Data are presented as means ±SEM. Statistical analyses were performed using GraphPad Prism®
5.0 and p-values of <0.05 were considered statistically significant. mRNA levels in VSMC
primary cultures from WKY and SHR rats were analyzed by a two-tailed t-test. Serum starvation
mRNA and protein data, as well as mammalian two-hybrid data, were analyzed by one-way
analysis of variance (ANOVA) with Tukey’s Multiple Comparison test. Tissue mRNA levels,
MTT assay data, and cell count data were analyzed by two-way ANOVA followed by
Bonferroni posttests. MTT assay data were also subjected to nonlinear regression and analyzed
by F test.
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3 RESULTS
3.1 DIFFERENTIAL EXPRESSION OF GPSM3 IN WKY AND SHR RATS

RNA was extracted from WKY-derived and SHR-derived VSMCs, reverse transcribed, and
subjected to qPCR. GPSM3 mRNA levels were assessed relative to β2-microglobulin mRNA
levels. GPSM3 transcript levels were significantly increased in SHR-derived VSMCs relative to
WKY-derived VSMCs by approximately two-fold (p < 0.05) (Figure 3.1). GPSM3 transcript
levels were also assessed in various tissues from WKY and SHR rats to ascertain whether or not
this model of hypertension resulted in changes to GPSM3 levels as is seen in vascular smooth
muscle cells. The investigated tissues included heart, aorta, liver, lung, spleen, and leukocytes.
RNA was extracted from these tissues, reverse transcribed, and subjected to qPCR. GPSM3
mRNA levels were assessed relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
mRNA levels. The GPSM3 expression profile obtained from these tissues is comparable to that
seen in previous studies (Cao et al. 2004; Zhao et al. 2010). GPSM3 transcript levels in the heart
and liver were low relative to the spleen, leukocytes, and lungs (Figure 3.2). Furthermore,
GPSM3 transcript levels were shown to be relatively high in aortic tissue for the first time.
GPSM3 levels were significantly increased in the spleen of SHR rats relative to WKY rat spleen,
with a p value less than 0.01. No significant differences were observed in the other tissues.

Relative GPSM3 Expression
[GPSM3/β 2-microglobulin]
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Figure 3.1. GPSM3 mRNA levels in WKY-derived and SHR-derived VSMCs. GPSM3
mRNA levels were assessed relative to β2-microglobulin mRNA levels. Data are presented as
means ± SEM of seven independent experiments (N=7) performed in triplicate. Statistical
analysis was done using an unpaired t-test. *P<0.05.
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Figure 3.2. GPSM3 mRNA levels in different WKY and SHR rat tissue types. GPSM3
mRNA levels were assessed relative to GAPDH mRNA levels. Data are presented as means ±
SEM of three to four independent experiments (N≥3) performed in triplicate. Statistical analyses
were done using two-way ANOVA followed by Bonferroni posttests. **P<0.01.
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3.2 GPSM3 EXPRESSION AND RATE OF CELL DIVISION

VSMCs were serum starved by using serum-free medium to induce reversible cell cycle arrest
(Chen et al. 2012). This was followed by the reintroduction of serum-containing medium to
induce synchronized progression through the G2 and M phases of the cell cycle, simulating an
increased rate of proliferation (Chen et al. 2012). Actively proliferating cells not subjected to this
protocol were used as a control. Overall RNA and protein synthesis is relatively unaffected by
the protocol (Zetterberg & Sköld 1969). Therefore, changes in gene expression can be indicative
of that gene playing a role in the rate of cell division.

Protein and mRNA levels were measured in both WKY- and SHR-derived VSMCs. GPSM3
mRNA levels in WKY-derived VSMCs showed no changes in response to serum starvation and
serum replacement (Figure 3.3). GPSM3 mRNA levels in SHR-derived VSMCs, however,
showed a significant decrease in response to serum starvation (p value less than 0.05), and levels
returned to control levels following serum replacement (Figure 3.4). GPSM3 mRNA levels were
assessed relative to β2-microglobulin mRNA levels. GPSM3 protein could not be detected by
immunoblot in cell lysates from WKY-derived VSMCs (Figure 3.5). The same trend observed
with mRNA in SHR-derived VSMCs was found with GPSM3 protein levels (Figure 3.6).
GPSM3 protein levels decreased in response to serum starvation, and returned to levels
comparable to control levels following serum replacement.
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Figure 3.3. Effect of serum deprivation and serum replacement on GPSM3 mRNA levels in
WKY-derived VSMCs. Cells were treated for 48 hours with serum-free medium (serum dep.),
followed by 48 hours of medium with 10% FBS (serum rep.). Actively proliferating cells were
used as a control. GPSM3 mRNA levels were assessed relative to β2-microglobulin mRNA
levels. Data are presented as mean ± SEM of three to five independent experiments (N≥3)
performed in triplicate. Statistical analyses were done using one-way ANOVA followed by
Tukey’s Multiple Comparison test.
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Figure 3.4. Effect of serum deprivation and serum replacement on GPSM3 mRNA levels in
SHR-derived VSMCs. Cells were treated for 48 hours with serum-free medium (serum dep.),
followed by 48 hours of medium with 10% FBS (serum rep.). Actively proliferating cells were
used as a control. GPSM3 mRNA levels were assessed relative to β2-microglobulin mRNA
levels. Data are presented as mean ± SEM of five to eight independent experiments (N≥5)
performed in triplicate. Statistical analyses were done using one-way ANOVA followed by
Tukey’s Multiple Comparison test. *P<0.05.
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Figure 3.5 (previous page). Effect of serum deprivation and serum replacement on GPSM3
protein levels in WKY-derived VSMCs. (A) Cells were treated for 48 hours with serum-free
medium (serum dep.), followed by 48 hours of medium with 10% FBS (serum rep.). Actively
proliferating cells were used as a control. GPSM3 protein levels were assessed relative to βtubulin protein levels. Data are presented as mean ± SEM of three independent experiments
(N=3). Statistical analyses were done using one-way ANOVA followed by Tukey’s Multiple
Comparison test. (B) Representative immunoblot of serum deprivation and replacement
experiment. The upper immunoblot was probed for GPSM3 protein. The lower immunoblot was
probed for β-tubulin protein.
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Figure 3.6 (previous page). Effect of serum deprivation and serum replacement on GPSM3
protein levels in SHR-derived VSMCs. (A) Cells were treated for 48 hours with serum-free
medium (serum dep.), followed by 48 hours of medium with 10% FBS (serum rep.). Actively
proliferating cells were used as a control. GPSM3 protein levels were assessed relative to βtubulin protein levels. Data are presented as mean ± SEM of five independent experiments
(N=5). Statistical analyses were done using one-way ANOVA followed by Tukey’s Multiple
Comparison test. (B) Representative immunoblot of serum deprivation and replacement
experiment. The upper immunoblot was probed for GPSM3 protein. The lower immunoblot was
probed for β-tubulin protein.
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HEK-293 cells were transfected with 400 ng of either EYFP or EYFP-GPSM3 DNA plasmid and
plated at approximately 8% confluency. Transfection of cells with EYFP-GPSM3 resulted in
greater absorbance readings on day 1 and day 2 relative to the cells transfected with EYFP with p
values less than 0.01 and 0.05, respectively (Figure 3.7). Cell populations transfected with
EYFP-GPSM3 appeared to reach confluence one day earlier, or 33% faster, compared to the
control cell populations. To further analyze the data, nonlinear regression was performed using
an exponential plateau equation to compare the growth rates of the two groups of cells. The
growth rate plus or minus standard error of cells transfected with EYFP-GPSM3 plasmid was
0.7228 ± 0.1076 days-1 with a doubling time of 0.96 ± 0.14 days. The growth rate of cells
transfected with EYFP plasmid was 0.3935 ± 0.0962 days-1 with a doubling time of 1.76 ± 0.43
days. An F test was conducted, where both data sets were fit simultaneously with common
minimum and maximum values and independent values of the growth rate k (either independent
between data sets or forced to be common between the two data sets). Holding the parameter
common for the two data sets caused a significant decrease in the goodness of the fit (as
indicated by an increase in the sum of the squares), thus indicating that they are significantly
different with a p value less than 0.05. Therefore, the growth rate of the cells transfected with
EYFP-GPSM3 was found to be significantly higher than the control group.

The results of counting cells expressing EFYP-GPSM3 or EYFP were similar to those obtained
by the MTT assay. Cells transfected with EYFP-GPSM3 had a significantly higher cell
population size on day 2 compared to those transfected with EYFP (Figure 3.8). Thus, higher
rates of cell division are correlated with higher levels of GPSM3, and increasing the expression
of GPSM3 appears to be sufficient to increase the rate of proliferation of cells.
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Figure 3.7. Effect of EYFP-tagged GPSM3 transfection on cell proliferation in HEK-293
cells as measured by MTT assay. HEK-293 cells were transfected with either EYFP-GPSM3or EYFP-encoding DNA plasmid and seeded in a 24-well plate. Cells were treated with MTT
reagent for 2 hours and then formazan crystals were recovered and solubilized in DMSO.
Absorbance was measured at 595 nm. Data are presented as mean ± SEM of five independent
experiments (N=5) performed in triplicate. Statistical analyses were done using two-way
ANOVA followed by Bonferroni posttests. *P<0.05. **P<0.01.
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Figure 3.8. Effect of EYFP-tagged GPSM3 transfection on cell proliferation in HEK-293
cells as measured by cell counting. HEK-293 cells were transfected with either EYFP-GPSM3or EYFP-containing plasmid and seeded in a 24-well plate. Cell counts were performed using
ImageJ software. Data are presented as mean ± SEM of three independent experiments (N=3)
performed in triplicate. Statistical analyses were done using two-way ANOVA followed by
Bonferroni posttests. *P<0.05.
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3.3 GPSM3 LOCALIZATION DURING MITOSIS IN VASCULAR SMOOTH MUSCLE
CELLS

N values for images of each cell type during each stage of mitosis can be found in Table 3.1. In
interphase, GPSM3 localized to the nucleus with limited expression in the cytosol in both WKY
and SHR vascular smooth muscle cells (Figure 3.9). Little to no co-localization between GPSM3
and β-tubulin was observed during interphase. Cells in metaphase showed clear co-localization
between GPSM3 and β-tubulin, presumably along the mitotic spindle fibers that attach to
chromatin lined up at the metaphase plate (Figure 3.10A). The same co-localization of GPSM3
and β-tubulin was seen during anaphase as the chromatin were pulled to opposite ends of the
dividing cells (Figure 3.11A). Finally, co-localization was observed between GPSM3 and βtubulin during telophase at the midbody (Figure 3.12A).

As a control, primary antibodies were incubated overnight at 4 °C with 10 µg/ml anti-GPSM3
primary antibody blocking peptide before use in order to confirm that the anti-GPSM3 primary
antibody was in fact binding specifically to GPSM3 protein. After incubation,
immunofluorescent labeling was carried out as described previously. Co-localization between
GPSM3 and β-tubulin was no longer seen during metaphase (Figure 3.10B), anaphase (Figure
3.11B), or telophase (Figure 3.12B). Any remaining fluorescence seen with the anti-GPSM3
primary antibody and the AlexaFluor 468 goat anti-rabbit secondary antibody can be attributed
to non-specific binding by the anti-GPSM3 primary antibody. To further confirm the validity of
this antibody for immunofluorescent labeling, HEK-293 cells were subjected to a protocol
identical to that for WKY VSMCs. No co-localization was observed between GPSM3 and β-
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Table 3.1. N values of immunofluorescently labeled images of vascular smooth muscle cells
and human embryonic kidney 293 cells in different stages of mitosis.
Stage of
Mitosis
Interphase
Metaphase
Anaphase
Telophase

VSMC
WKY
8
13
4
11

SHR
8
3
3
3

VSMC
(with blocking peptide)
WKY
SHR
0
0
3
3
3
3
0
3

HEK-293
0
5
3
0
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Figure 3.9. Localization of GPSM3 and β-tubulin during interphase in WKY and SHR
vascular smooth muscle cells. Primary vascular smooth muscle cells were serum starved for 24
hours, and following serum replacement (20 hours for WKY cells, 12 hours for SHR cells) cells
were fixed and subjected to immunofluorescent labeling. Cells were probed with anti-GPSM3
primary antibody (1:500) and anti-β-tubulin primary antibody (1:500), followed by AlexaFluor
488 goat anti-rabbit secondary antibody (1:500) and AlexaFluor 568 goat anti-mouse secondary
antibody (1:500). Nuclei were stained using DAPI. Panels labeled in top left corners. Cell type
indicated by label to left of panels. Cells imaged are representative of the majority of cells
imaged.
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Figure 3.10 (previous page). Co-localization of GPSM3 and β-tubulin during metaphase in
WKY and SHR vascular smooth muscle cells. (A) Primary vascular smooth muscle cells were
serum starved for 24 hours, and following serum replacement (20 hours for WKY cells, 12 hours
for SHR cells) cells were fixed and subjected to immunofluorescent labeling. Cells were probed
with anti-GPSM3 primary antibody (1:500) and anti-β-tubulin primary antibody (1:500),
followed by AlexaFluor 488 goat anti-rabbit secondary antibody (1:500) and AlexaFluor 568
goat anti-mouse secondary antibody (1:500). Nuclei were stained using DAPI. Panels labeled in
top left corners. Cell type indicated by label to left of panels. (B) Anti-GPSM3 primary antibody
(1:500) and anti-β-tubulin primary antibody (1:500) were incubated overnight at 4 °C with 10
µg/ml anti-GPSM3 primary antibody blocking peptide before use (as in panel A). Cells imaged
are representative of the majority of cells imaged.
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Figure 3.11 (previous page). Co-localization of GPSM3 and β-tubulin during anaphase in
WKY and SHR vascular smooth muscle cells. (A) Primary vascular smooth muscle cells were
serum starved for 24 hours, and following serum replacement (20 hours for WKY cells, 12 hours
for SHR cells) cells were fixed and subjected to immunofluorescent labeling. Cells were probed
with anti-GPSM3 primary antibody (1:500) and anti-β-tubulin primary antibody (1:500),
followed by AlexaFluor 488 goat anti-rabbit secondary antibody (1:500) and AlexaFluor 568
goat anti-mouse secondary antibody (1:500). Nuclei were stained using DAPI. Panels labeled in
top left corners. Cell type indicated by label to left of panels. (B) Anti-GPSM3 primary antibody
(1:500) and anti-β-tubulin primary antibody (1:500) were incubated overnight at 4 °C with 10
µg/ml anti-GPSM3 primary antibody blocking peptide before use (as in panel A). Cells imaged
are representative of the majority of cells imaged.

80

A
GPSM3

β-tubulin

DAPI

Merge

GPSM3

β-tubulin

DAPI

Merge

WKY

SHR

B
GPSM3

SHR

Figure 3.12.

β-tubulin

DAPI

Merg
e

81
Figure 3.12 (previous page). Co-localization of GPSM3 and β-tubulin during telophase in
WKY and SHR vascular smooth muscle cells. (A) Primary vascular smooth muscle cells were
serum starved for 24 hours, and following serum replacement (20 hours for WKY cells, 12 hours
for SHR cells) cells were fixed and subjected to immunofluorescent labeling. Cells were probed
with anti-GPSM3 primary antibody (1:500) and anti-β-tubulin primary antibody (1:500),
followed by AlexaFluor 488 goat anti-rabbit secondary antibody (1:500) and AlexaFluor 568
goat anti-mouse secondary antibody (1:500). Nuclei were stained using DAPI. Panels labeled in
top left corners. Cell type indicated by label to left of panels. (B) Anti-GPSM3 primary antibody
(1:500) and anti-β-tubulin primary antibody (1:500) were incubated overnight at 4 °C with 10
µg/ml anti-GPSM3 primary antibody blocking peptide before use (as in panel A). Cells imaged
are representative of the majority of cells imaged.
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tubulin antibody signals in HEK-293 cells (Figure 3.13). Similar to the observation of nonspecific binding in vascular smooth muscle cells when anti-GPSM3 primary antibody blocking
peptide was used, diffuse and non-specific staining was seen in HEK-293 cells as well.
Additional controls were also used to confirm the validity of these antibodies for
immunofluorescent labeling. GPSM3 and β-tubulin were labeled independently from one another
to ensure neither antibody was influencing the localization of the other (Figures 3.14 and 3.15).
Immunofluorescent labeling with only the secondary antibodies was performed to demonstrate
that these antibodies were not responsible for the observed localization of patterns (Figure 3.16).

3.4 MAMMALIAN TWO-HYBRID ASSAY FOR GPSM3 PROTEIN INTERACTORS

The heterotrimeric G protein subunits tested were as follows: Gαi1, Gαi2, Gαo, GαoQ205L,
Gαs, and Gβ1 (Figure 3.17). As expected, the assay showed an interaction between GPSM3 and
both Gαi1 and Gαi2. Both interactions gave strong positive signals that were statistically
significant relative to the negative control (p value less than 0.001). Gαs and Gαo did not
produce a detectable signal. Gαo-Q205L, a form of the Gαo subunit containing a mutation that
renders it constitutively active, failed to produce a signal significantly greater than that of the
negative control. No interaction was detected between GPSM3 and Gβ1 either. As expected, all
negative vector controls failed to produce detectable signals (Figure 3.18).
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Figure 3.13. Localization of GPSM3 and β-tubulin during metaphase in HEK-293 cells.
HEK-293 cells were serum starved for 24 hours, and 20 hours after serum replacement cells were
fixed and subjected to immunofluorescent labeling. Cells were probed with anti-GPSM3 primary
antibody (1:500) and anti-β-tubulin primary antibody (1:500), followed by AlexaFluor 488 goat
anti-rabbit secondary antibody (1:500) and AlexaFluor 568 goat anti-mouse secondary antibody
(1:500). Nuclei were stained using DAPI. Panels labeled in top left corners. Cell type indicated
by label to left of panels. Cells imaged are representative of the majority of cells imaged.
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Figure 3.14. Localization of GPSM3 during metaphase and telophase in WKY vascular
smooth muscle cells. Primary vascular smooth muscle cells were serum starved for 24 hours,
and 20 hours following serum replacement cells were fixed and subjected to immunofluorescent
labeling. Cells were probed with anti-GPSM3 primary antibody (1:500), followed by AlexaFluor
488 goat anti-rabbit secondary antibody (1:500). Nuclei were stained using DAPI. Panels labeled
in top left corners. Cell cycle stage indicated by label to left of panels. Cells imaged are
representative of the majority of cells imaged. N=3.
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Figure 3.15. Localization of β-tubulin during metaphase and telophase in WKY vascular
smooth muscle cells. Primary vascular smooth muscle cells were serum starved for 24 hours,
and 20 hours following serum replacement cells were fixed and subjected to immunofluorescent
labeling. Cells were probed with anti-β-tubulin primary antibody (1:500), followed by
AlexaFluor 568 goat anti-mouse secondary antibody (1:500). Nuclei were stained using DAPI.
Panels labeled in top left corners. Cell cycle stage indicated by label to left of panels. Cells
imaged are representative of the majority of cells imaged. N=3.
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Figure 3.16. Localization of secondary antibodies during metaphase and telophase in WKY
vascular smooth muscle cells. Primary vascular smooth muscle cells were serum starved for 24
hours, and 20 hours following serum replacement cells were fixed and subjected to
immunofluorescent labeling. Cells were probed with AlexaFluor 488 goat anti-rabbit secondary
antibody (1:500) and AlexaFluor 568 goat anti-mouse secondary antibody (1:500). Nuclei were
stained using DAPI. Panels labeled in top left corners. Cell cycle stage indicated by label to left
of panels. Cells imaged are representative of the majority of cells imaged. N=3.
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Figure 3.17.
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Figure 3.17 (previous page). Mammalian Two-Hybrid luciferase assay results between
GPSM3 and heterotrimeric G proteins. DNA plasmids were made by subcloning genes of
interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, were then
transiently transfected into HEK-293 cells and luminescence was measured to detect proteinprotein interactions. (A) indicates that the protein’s corresponding gene has been subcloned into
the pACT vector. (B) indicates that the protein’s corresponding gene has been subcloned into the
pBIND vector. All data are presented as luciferase/Renilla output, which has been normalized to
the positive and negative control values to produce a relative response ratio (RRR). Data are
presented as mean ± SEM of three to eight independent experiments (N≥3) performed in
triplicate. Statistical analyses were done using one-way ANOVA followed by Tukey’s Multiple
Comparison test. ***P<0.001.
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Figure 3.18.
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Figure 3.18 (previous page). Mammalian Two-Hybrid luciferase assay results of
heterotrimeric G protein vector controls. DNA plasmids were made by subcloning genes of
interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, were then
transiently transfected into HEK-293 cells and luminescence was measured to detect proteinprotein interactions. (A) indicates that a gene has been subcloned into the pACT vector. (B)
indicates that a gene has been subcloned into the pBIND vector. All data are presented as
luciferase/Renilla output, which has been normalized to the positive and negative control values
to produce a relative response ratio (RRR). Data are presented as mean ± SEM of three
independent experiments (N=3) performed in triplicate. Statistical analyses were done using oneway ANOVA followed by Tukey’s Multiple Comparison test.
.
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Proteins associated with cell division are the second class of proteins tested for interaction with
GPSM3 (Figure 3.19). NuMA and ninein both failed to produce a statistically significant signal.
GPSM3 also failed to interact with itself. As expected, all negative vector controls failed to
produce detectable signals (Figure 3.20).

The third and final class of proteins consists of those predicted to interact with GPSM3 by online
databases (Figure 3.21). SELPLG failed to produce a detectable signal. FGFR3 and supervillin
both produced positive signals above that of the negative control, however neither or these
signals were statistically significant as assessed using ANOVA followed by Tukey’s Multiple
Comparison test. As expected, all negative vector controls failed to produce detectable signals
(Figure 3.22).
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Figure 3.19.
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Figure 3.19 (previous page). Mammalian Two-Hybrid luciferase assay results between
GPSM3 and mitosis-related proteins of interest. DNA plasmids were made by subcloning
genes of interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector,
were then transiently transfected into HEK-293 cells and luminescence was measured to detect
protein-protein interactions. (A) indicates that a gene has been subcloned into the pACT vector.
(B) indicates that a gene has been subcloned into the pBIND vector. All data are presented as
luciferase/Renilla output, which has been normalized to the positive and negative control values
to produce a relative response ratio (RRR). Data are presented as mean ± SEM of three
independent experiments (N=3) performed in triplicate. Statistical analyses were done using oneway ANOVA followed by Tukey’s Multiple Comparison test.
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Figure 3.20.
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Figure 3.20 (previous page). Mammalian Two-Hybrid luciferase assay results of mitosisrelated gene of interest vector controls. DNA plasmids were made by subcloning genes of
interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, were then
transiently transfected into HEK-293 cells and luminescence was measured to detect proteinprotein interactions. (A) indicates that a gene has been subcloned into the pACT vector. (B)
indicates that a gene has been subcloned into the pBIND vector. All data are presented as
luciferase/Renilla output, which has been normalized to the positive and negative control values
to produce a relative response ratio (RRR). Data are presented as mean ± SEM of three
independent experiments (N=3) performed in triplicate. Statistical analyses were done using oneway ANOVA followed by Tukey’s Multiple Comparison test.
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Figure 3.21.
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Figure 3.21 (previous page). Mammalian Two-Hybrid luciferase assay results between
GPSM3 and online database-predicted interactors. DNA plasmids were made by subcloning
genes of interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector,
were then transiently transfected into HEK-293 cells and luminescence was measured to detect
protein-protein interactions. (A) indicates that the protein’s corresponding gene has been
subcloned into the pACT vector. (B) indicates that the protein’s corresponding gene has been
subcloned into the pBIND vector. All data are presented as luciferase/Renilla output, which has
been normalized to the positive and negative control values to produce a relative response ratio
(RRR). Data are presented as mean ± SEM of three to five independent experiments (N≥3)
performed in triplicate. Statistical analyses were done using one-way ANOVA followed by
Tukey’s Multiple Comparison test.
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Figure 3.22.

99
Figure 3.22 (previous page). Mammalian Two-Hybrid luciferase assay results of online
database-predicted interactor vector controls. DNA plasmids were made by subcloning genes
of interest into the pACT and pBIND vectors. Both vectors, as well as the pG5luc vector, were
then transiently transfected into HEK-293 cells and luminescence was measured to detect
protein-protein interactions. (A) indicates that a gene has been subcloned into the pACT vector.
(B) indicates that a gene has been subcloned into the pBIND vector. All data are presented as
luciferase/Renilla output, which has been normalized to the positive and negative control values
to produce a relative response ratio (RRR). Data are presented as mean ± SEM of three
independent experiments (N=3) performed in triplicate. Statistical analyses were done using oneway ANOVA followed by Tukey’s Multiple Comparison test.
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4 DISCUSSION
4.1 SUMMARY OF NOVEL FINDINGS

The functional role of GPSM3 in the cell remains poorly understood, especially compared to
other components of the G protein-mediated signaling machinery. I hypothesized that GPSM3
plays a role in cell division, likely via an as yet undefined interaction with the mitotic spindle. In
this study, GPSM3 transcript and protein levels were shown to be elevated in vascular smooth
muscle cells (VSMCs) taken from spontaneously hypertensive (SHR) rats compared to those
from normotensive Wistar-Kyoto (WKY) rats. In addition, a profile of GPSM3 transcript levels
was compiled for the first time from rat tissues. SHR spleen tissue had higher levels of GPSM3
transcript compared to its WKY counterpart. GPSM3 transcript levels were also detected in
aortic tissue at relatively high levels for the first time.

While heterotrimeric G protein subunits and GPSM motif-containing proteins have been linked
to cell division, such a role for GPSM3 has not been reported in the literature. The results of the
present study suggest that GPSM3 is indeed connected to the process of cell proliferation. In the
SHR VSMCs with elevated GPSM3 expression, depriving cells of serum to promote cell cycle
arrest resulted in decreased GPSM3 transcript and protein levels. Re-adding serum to these cells,
allowing them to reenter the cell cycle, led to transcript and protein levels returning to control
levels. GPSM3 expression seems to be linked to which stage of the cell cycle a cell is in. These
results also suggest that GPSM3 expression is regulated at the level of transcription. Two
independent experimental methods, an MTT assay and cell counting, showed that overexpression
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of EYFP-GPSM3 in HEK-293 cells results in an increased proliferation rate. This indicates that
changing GPSM3 expression is sufficient to significantly alter a cell’s rate of proliferation.

Immunofluorescent labeling in WKY and SHR VSMCs revealed that GPSM3 co-localizes with
β-tubulin during mitosis. During metaphase and anaphase, GPSM3 appears to localize to the
microtubules as they attach to and pull apart chromatin. In cytokinetic cells, GPSM3 localizes to
the microtubules in the midbody. These results suggest that GPSM3 functions in cell division via
interaction with the mitotic spindle and could influence spindle orientation, spindle position, and
chromosome segregation. Finally, the mammalian two-hybrid assay does not support previous
observations that GPSM3 interacts with Gβ1 and Gαo. The assay also provided evidence against
a number of hypothesized protein-protein interactions involving GPSM3.

Ultimately, the results of this study support the hypothesis that GPSM3 is involved in the process
of cell division. Expression of GPSM3 in VSMCs is linked to being in the cell cycle and
increasing expression increases proliferation rate. GPSM3 likely exerts its function in cell
division through an as yet undefined interaction with the mitotic spindle.

4.2 CONTRIBUTION OF RESEARCH TO CURRENT STATE OF KNOWLEDGE

Findings from this study have furthered our state of knowledge in three main categories: general
knowledge about GPSM3, our understanding of cell division, and, to a lesser extent, our
understanding of hypertension.
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4.2.1 CONTRIBUTION TO OUR GENERAL KNOWLEDGE OF GPSM3

The expression profile compiled from GPSM3 transcript levels in WKY and SHR rat tissues
(Figure 3.2) partially supports previously reported profiles from mouse and human tissues (Cao
et al. 2004; Zhao et al. 2010). The finding that GPSM3 is moderately to highly expressed in
spleen, lung and leukocytes is similar to mouse and human tissue. However, the finding that
levels of GPSM3 mRNA in heart and liver are relatively low is at odds with reports from mouse
and human tissues. For the first time, it is reported that GPSM3 transcript is present at high
levels in aortic tissue at well. These findings also contradict the assertion by Billard et al. 2014
that GPSM3 expression is highly restricted to immune system cells.

Immunofluorescent labeling of vascular smooth muscle cells in interphase showed GPSM3 to be
enriched in the nucleus and faintly detectable throughout the cytosol (Figure 3.9). Previous
reports show GPSM3 mainly present in the cytosol or enriched at the plasma membrane (Cao et
al. 2004; Giguère et al. 2013; Giguère, Laroche, Oestreich, Duncan, et al. 2012; Giguère,
Laroche, Oestreich & Siderovski 2012; Willard et al. 2008; Zhao & Chidiac 2015). However, the
COMPARTMENTS Subcellular localization database uses a sequence-based subcellular
localization prediction method to predict that GPSM3 would be distributed similarly to the
results seen in this study: enriched in the nucleus and present in the cytosol (Binder et al. 2014).
It is worth noting that these cells were primed to divide by first serum starving them and then
giving them serum-containing medium again in order to synchronize their cell cycles. This was
not performed on any of the cells imaged in previous reports.
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Regulation of GPSM3 expression has been studied very little. It has been reported that GPSM3
expression in immune cells changes in response to differentiation, but the underlying mechanism
remains unclear (Giguère et al. 2013; Gall, Schroer, et al. 2016). Our finding that GPSM3
transcript and protein levels change to a similar degree in response to serum starvation and serum
replacement (Figures 3.4 and 3.6) suggest that GPSM3 protein levels are modulated by
transcriptional regulatory mechanisms rather than via translational or post-translational
mechanisms, such as altered degradation. Two single nucleotide polymorphisms (SNPs) of the
human GPSM3 gene result in decreased transcript abundance due to reduced promoter activity
and these are inversely correlated with rheumatoid arthritis prevalence (Gall, Wilson, et al.
2016). Considering GPSM3 deficiency has been shown to act as a protective factor in a mouse
model of inflammatory arthritis (Giguère et al. 2013), our finding that GPSM3 is likely
transcriptionally regulated recalls the earlier report that GPSM3 SNPs that reduce transcript
abundance result in decreased rheumatoid arthritis risk. It would be interesting to see if these
polymorphisms are correlated with other disease states, especially hypertension and cancer.

In agreement with our findings (Figure 3.17), GPSM3 has been reported by multiple studies to
interact with Gαi subunits while it does not interact with Gαs (Zhao et al. 2010; Cao et al. 2004;
Kimple et al. 2004; Robichaux et al. 2015; Giguère, Laroche, Oestreich & Siderovski 2012;
Giguère, Laroche, Oestreich, Duncan, et al. 2012; Oner, Maher, et al. 2010). However, unlike
previous reports, our findings do not show that GPSM3 interacts with Gαo (Zhao et al. 2010) or
Gβ1 (Giguère, Laroche, Oestreich & Siderovski 2012). Gαo and a mutationally activated variant,
GαoQ205L, were both tested and neither returned statistically significant signals. GαoQ205L
was used to mimic the fluoroaluminate-activated version of Gαo that Zhao et al. 2010 showed
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was capable of interacting with GPSM3. GαoQ205L has had a glutamine at position 205 mutated
to become a leucine, and this is thought to result in persistent activation by inhibiting the GTPase
activity of the protein (Kroll et al. 1992). On the other hand, fluoroaluminate activates Gα
subunits by binding to the GDP-binding site next to GDP and mimicking the role of the γphosphate of GTP (Bigay et al. 1985). The resulting structure more closely resembles that of the
transition state for GTP hydrolysis than the ground state of an active Gα subunit (Kleuss et al.
1994). Therefore, GαoQ205L may be a more physiologically relevant model of activated Gαo
and this could account for the different results of these two studies.

Giguère et al. 2012 reported that GPSM3 is capable of interacting with the Gβ subunits Gβ1 to
Gβ4. Their study suggested that GPSM3 acts as a stabilizing chaperone of neosynthesized Gβ
subunits during transport to the plasma membrane and that the binding site overlaps the Nterminal side of the first GPSM motif in GPSM3. Other than in that study, no GPSM motifcontaining protein has yet been reported to interact with Gβ subunits. This finding could not be
replicated using Gβ1 in the mammalian two-hybrid assay. If GPSM3 does indeed act as a
chaperone for Gβ subunits, the signal shuttling them to the plasma membrane could potentially
interfere with the two-hybrid assay by preventing the DNA-binding domain from associating
with the luciferase reporter gene, thereby precluding the promotion of luciferase protein
synthesis by the transcriptional activation domain.
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4.2.2 CONTRIBUTION TO OUR KNOWLEDGE OF HYPERTENSION

Increased GPSM3 expression in vascular smooth muscle cells from SHR rats relative to WKY
rats (Figure 3.1) could be a protective factor in response to hypertensive conditions. Many
pathological conditions of the cardiovascular system such as hypertension, hypertrophy, and
heart failure have been linked to altered Gαi/o-mediated signaling (Sato & Ishikawa 2010). This
altered signaling is likely an adaptive response of the cardiovascular system. Gαi/o-mediated
signaling in the vasculature of SHR rats is reported to be elevated (Kost et al. 1999). Expression
of Gαi2/3 in the heart and Gαi2 in the aorta were reported to be increased in SHR rats compared
to WKY rats, while Gαs was unchanged (Anand-Srivastava 1992). Hypertension in SHR rats can
also be delayed by temporally inactivating Gαi/o-mediated signaling via pertussis toxin treatment
(Li & Anand-Srivastava 2002). Therefore, the inhibitory effect of GPSM3 on Gαi/o activation
could play a protective role in hypertension.

Increased GPSM3 expression in SHR VSMCs could also be a causative factor in the
hypertensive phenotype of SHR rats. The transition of smooth muscle cells from a contractile to
a proliferative, migratory phenotype is associated with cardiovascular disease (Dzau et al. 2002;
Fingerle et al. 1989; Sandison et al. 2016). Changes in GPSM3 expression have been linked to
differentiation, with higher GPSM3 levels associated with more mobile cell types (Giguère et al.
2013; Gall, Schroer, et al. 2016). Our finding that GPSM3 overexpression results in increased
proliferation (Figures 3.7 and 3.8) suggests that elevated GPSM3 in SHR VSMCs could foster a
more proliferative phenotype, thus leading to hypertension. Interestingly, blood pressure control
mechanisms in GPSM1 null mice are altered, as sensitivity to the vasodilator sodium
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nitroprusside (SNP) and baroreceptor reflex sensitivity were both reported to be elevated, while
the ability to return to pre-SNP arterial pressure levels was impaired (Blumer et al. 2008).

Finally, I also found that GPSM3 transcript levels are increased in SHR spleen tissue.
Hypertension is associated with increased immune activity (Sun et al. 2006). As immune cells,
particularly monocytes, are known to have relatively high GPSM3 expression, and the spleen has
been shown to act as a reservoir for the majority of monocytes in the body, this could account for
the higher levels of GPSM3 in SHR spleen tissue compared to spleen tissue from WKY rats
(Giguère et al. 2013; Swirski et al. 2009). Alternatively, GPSM3 deficiency in mice has been
linked to a decreased inflammatory response and decreased GPSM3 transcript levels in humans
are linked with decreased arthritis risk (Giguère et al. 2013; Gall, Wilson, et al. 2016). The heart,
brain, kidneys, and liver are reported to be inflamed in SHR rats (Sun et al. 2006). If the spleen is
also inflamed in these rats, this could account for the increased levels of GPSM3 transcript.

4.2.3 CONTRIBUTION TO OUR KNOWLEDGE OF CELL DIVISION

G proteins and GPSM motif-containing proteins play essential roles in the process of cell
division. Our data provide evidence of a role for GPSM3 in cell division for the first time.
GPSM3 expression appears to be linked to the cell cycle (Figures 3.4 and 3.6). Depriving SHR
VSMCs of serum in order to arrest the cell cycle resulted in GPSM3 mRNA levels significantly
decreasing and GPSM3 protein levels following a similar trend. Reintroducing serum into the
medium to allow re-entry into the cell cycle led to transcript and protein levels returning to
normal. GPSM2 and Gαi3 expression also change during the cell cycle, being upregulated during
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metaphase in mammalian cells (Blumer et al. 2006). Expression of other protein classes, such a
cyclins and cyclin-dependent kinases (CDKs), also vary throughout the cell cycle and can
determine the proliferative fate of a cell (Yang et al. 2006; Shankland et al. 1996).

Overexpressing EYFP-tagged GPSM3 in HEK-293 cells resulted in an increased proliferation
rate, as measured by both MTT assay and cell counting (Figures 3.7 and 3.8). Therefore higher
levels of GPSM3 are correlated with higher rates of cell division, and increasing the expression
of GPSM3 appears to be sufficient to increase proliferation rates. This could partly explain why
SHR VSMCs, which have higher GPSM3 transcript and protein levels than WKY VSMCs
(Figures 3.1, 3.5, and 3.6), divide at a rate approximately 1.75 times greater than their WKY
counterparts (Hadrava et al. 1991). In addition, this could give insight into the elevated levels of
GPSM3 in aortic tissue taken from abdominal aortic aneurism (AAA) (Lenk et al. 2007). AAA is
associated with a decreased number of smooth muscle cells; therefore GPSM3 levels may be
elevated in the smooth muscle cells in order to stimulate proliferation. However, an alternate
explanation could be that the elevated levels of GPSM3 are a result of the immune cells known
to infiltrate aortic tissue in AAA. GPSM3 expression is relatively high in immune cells and these
cells could be responsible for the elevated GPSM3 levels reported.

The present findings may also indicate a role for GPSM3 in cancer biology. GPSM3 expression
increases by greater than two-fold in prostate cancer models which mimic angiogenesis (Lapan
et al. 2009). Furthermore, GPSM3 has been identified as a gene required for the proliferation of
p53 human cancer cell lines (Xie et al. 2012). GPSM2 levels are elevated in most breast cancer
cell lines and knocking down GPSM2 in those cells results in significant growth suppression and
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incomplete cell division (Fukukawa et al. 2010b). Since elevated GPSM3 levels correlate with
and may in fact cause increased rates of cell division, GPSM3 could be an attractive therapeutic
target for cancer treatment.

GPSM3 was observed to co-localize with β-tubulin at the spindle fibers during metaphase and
anaphase (Figures 3.10 and 3.11), and at the midbody during telophase (Figure 3.12). GPSM2
has been shown to localize to these same regions during these three stages of mitosis as well in
breast cancer cells (Fukukawa et al. 2010b). Gαo co-localizes with β-tubulin at the mitotic
spindle in animal and human cell lines as well (Wu & Lin 1994), and Gβ subunits are
incorporated into the mitotic spindle and interact with tubulin in bovine brain cells according to
Wu et al. 1998. Gαi2, on the other hand, has been reported to bind to the kinetochores of
chromatin in 3T3 cells (Crouch & Simson 1997). Since GPSM2 has been reported to directly
interact with Gαo and that overexpression of Gαo subunits are capable of redirecting localization
of GPSM2 in the cell, it is likely that GPSM2 is being recruited to the spindle fibers by Gαo
(Kaushik et al. 2003). Our findings also suggest that GPSM3 interacts with Gαi1 and Gαi2
(Figure 3.17). Therefore GPSM3 may be recruited to the spindle fibers by one of the members of
the Gαi/o family.

Considering the many parallels between the findings of this study and previous reports on
GPSM2, I propose that GPSM3 may function in a similar capacity to GPSM2. The tertiary
complex consisting of Gαi, GPSM2, and NuMA plays a critical role in the generation of pulling
forces on the mitotic spindle and spindle pole orientation and positioning (Du & Macara 2004;
Merdes et al. 2000; Tall & Gilman 2005). Rapid cycling of nucleotide exchange on the Gαi
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subunit is thought to contribute to these pulling forces, and is accomplished by GAP and GEF
activity of accessory proteins (Tall & Gilman 2005; Dave et al. 2009). GPSM3 could be part of
an alternative complex that plays a related but different role from GPSM2 in cell division. It is a
particularly attractive candidate for such a role as its reported GEF activity could aid rapid
cycling of nucleotide exchange (Zhao et al. 2010).

4.3 EXPERIMENTAL METHODS: NOTES AND LIMITATIONS
4.3.1 SERUM STARVATION

This study used serum starvation to induce reversible cell cycle arrest (Chen et al. 2012), which
has been shown to not change overall RNA and protein synthesis in a cell (Zetterberg & Sköld
1969). Changes in GPSM3 transcript and protein levels were therefore thought to be the result of
changes in the cell cycle. However, serum starvation is a potent cellular stress and it cannot be
ruled out that GPSM3 expression changes in response to cellular stress. It should also be noted
that serum starvation has been shown to induce transcriptional changes in pathways related to
cancer, cell death, apoptosis, and the cell cycle in the LoVo colon cancer cell line (Zheng et al.
2016).

4.3.2 EYFP-TAGGED GPSM3

In the MTT assay and cell counting experiments, HEK-293 cells were transiently transfected
with either EYFP-tagged GPSM3 or EYFP. The difference in proliferation rates between these
two groups of cells was attributed to GPSM3. Since linking a fluorescent protein to a protein of
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interest and the position of this linkage can affect the localization and functionality of that
protein of interest (Snapp 2005), it is conceivable that the same effect would not occur using
untagged GPSM3.

4.3.3 MAMMALIAN TWO-HYBRID ASSAY

I failed to identify any novel GPSM3 interactors using the mammalian two-hybrid assay. The
proteins of interest that were tested were chosen for specific reasons. NuMA was chosen due to
its functional role with GPSM2 and the many similarities between GPSM3 and GPSM2. Ninein
was chosen because it plays a role in anchoring microtubules to the centrosome and due to its
high expression in the vasculature of normal and pathological human tissues, making it an
attractive target (Matsumoto et al. 2008; Mogensen et al. 2000). Neither of these proteins when
tested produced statistically significant signals (Figure 3.19). Previously in our lab, a coimmunoprecipitation assay using His-tagged GPSM3 as bait and probing for β-tubulin failed to
indicate that the two proteins directly interact or co-exist in a complex. For this reason, β-tubulin
was not included in the list of proteins to test for interaction with GPSM3.

The remaining three proteins, FGFR3, supervillin, and SELPLG, were chosen because they were
predicted as likely GPSM3 interactors by the web resource STRING (Search Tool for the
Retrieval of INteracting Genes) database (Szklarczyk et al. 2015). In addition to making its own
predictions, STRING also uses protein-protein interaction prediction data and resources from
over twenty other online resources. GPSM motifs can be regulated via phosphorylation
(Hollinger et al. 2003; Blumer et al. 2003; Fukukawa et al. 2010b) and FGFR3 contains a
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cytosolic tyrosine kinase domain (Keegan et al. 1991; Bocharov et al. 2013). I therefore reasoned
that FGFR3 could be regulating GPSM3 via its kinase activity. SELPLG shares many of the
associations GPSM3 has, being linked to cardiovascular disease (Tregouet et al. 2003; Volcik et
al. 2009), inflammation (Sun et al. 2016), and cell migration, and reported expression in immune
cells (Luan et al. 2010). GPSM2 and NuMA require Afadin, an actin-binding protein, for proper
cortical localization via direct interaction between GPSM2 and Afadin (Carminati, Gallini, et al.
2016; Carminati, Cecatiello, et al. 2016). Supervillin contains actin-binding sites and is
associated with cell motility and cancer (Fedechkin et al. 2013). I predicted that supervillin might
interact with GPSM3 in a role analogous to that of Afadin with GPSM2. None of these proposed
interactions were confirmed by the mammalian two-hybrid assay (Figure 3.21). It should be
noted that SELPLG no longer appears as a predicted GPSM3 interactor in the STRING database
since it was updated. The intragenic microRNA database still lists SELPLG as a GPSM3
interactor, listing STRING as its source (miRAD 2016).

Mammalian Two-Hybrid assays have the potential to produce false negative results. First, the
size and orientation of the proteins of interest could interfere with the ability of the fused DNAbinding domain and transcriptional activation domain from coming into close contact and
promoting the synthesis of luciferase. Supervillin, ninein, and NuMA are all over 2000 amino
acids in length, which could have interfered with the ability of the fused domains from coming
into close contact. Second, the fused domains could sterically hinder the ability of the proteins of
interest to associate (Lievens et al. 2009). These situations likely account for vector
directionality, as observed with the tested interaction between GPSM3 and Gαi1/2 (Figure 3.17).
Third, one or more of the proteins of interest may be tethered to a part of the cell preventing the
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complex from coming into contact with the reporter gene. For example, supervillin may be
tethered to actin filaments via its actin-binding domains. Finally, if the tested proteins are part of
a larger complex, other components of the complex may need to be overexpressed as well in
order for the complex to form and a signal to be produced.

4.4 FUTURE DIRECTIONS

The results of this study provide strong evidence of a role for GPSM3 in cell division. The
specific function of GPSM3 and how it achieves that function remain to be elucidated.
Overexpression of GPSM3 was shown to increase the rate of proliferation of cells. Future studies
should determine whether using siRNA to knockdown the level of GPSM3 in a cell produces the
opposite effect, decreasing proliferation rate. If this is indeed the case, targeted gene therapy
against GPSM3 could be a potential treatment for certain cancers. Knockdown of GPSM1 and
GPSM2 homologues in C. elegans leads to incorrect spindle orientations and decreased spindle
pulling forces (Srinivasan et al. 2003; Schneider & Bowerman 2003b). Overexpression of
GPSM2 in kidney cells results in oscillations and rotations of the mitotic spindle which indicate
strong pulling forces being exerted on astral microtubules (Du & Macara 2004). Future
experiments should overexpress and knock down GPSM3 to determine whether a similar
phenotype occurs.

GPSM3 null mice have been successfully bred (Giguère et al. 2013). Considering GPSM3 is
elevated in SHR VSMCs and they divide at a faster rate than WKY VSMCs (Hadrava et al.
1991), measuring the proliferation rate in VSMCs taken from GPSM3 null mice would be

113
interesting. Spindle orientation and pulling forces should also be studied in the smooth muscle
cells and compared to those that endogenously express GPSM3. If proliferation rate is indeed
decreased in these VSMCS, overexpressing GPSM3 in these cells to rescue a normal division
rate phenotype could strengthen the argument that GPSM3 levels are correlated with
proliferation rate.

Coupling between GPSM motif-containing proteins and Gα proteins is necessary for mitosis to
occur properly. Blocking this interaction via a point mutation which prevents the GPSM motif
from binding to Gαi results in cytokinetic defects and abnormal mitotic spindle rocking (Willard
et al. 2008; Cho & Kehrl 2007). It is also possible to mutate the GPSM motifs in GPSM3 so that
they are incapable of interacting with Gα subunits (Zhao et al. 2010). Studying the mitotic
spindle and cytokinesis in cells that have this mutation could help demystify the role GPSM3
plays in cell division.

Finally, like GPSM2, GPSM3 most likely interacts with other proteins in order to fulfill its role
in cell division. Therefore identifying these interaction partners would be an important step in
determining the function of GPSM3. This study suggests that despite sharing many similarities
with GPSM2, GPSM3 may not interact with the same proteins. Online resource databases such
as STRING also appear to struggle to correctly predict GPSM3 interactors. Therefore, a yeast
two-hybrid assay could be used to screen a smooth muscle cell cDNA library for proteins that
interact with GPSM3. Identifying GPSM3 interaction partners could be the turning point in
ascertaining its function in cell division.
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4.5 CONCLUSIONS

Our results provide evidence that GPSM3 plays a role in the process of cell division. GPSM3
levels are correlated with changes in the cell cycle of vascular smooth muscle cells from
spontaneously hypertensive rats. Overexpression of EYFP-tagged GPSM3 in HEK-293 cells
results in a significant increase in the proliferation rate of those cells. Furthermore, in vascular
smooth muscle cells, GPSM3 co-localizes with β-tubulin at the mitotic spindle during metaphase
and anaphase and at the midbody during telophase. Therefore, GPSM3 appears to play a role in
the process of cell division, likely via interaction with the mitotic spindle.
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6 APPENDIX 1
5.1 SUPPLEMENTAL FIGURES
Localization of GPSM3 during mitosis was first investigated by transfecting HEK-293 cells with
EYFP-tagged GPSM3 plasmid and labeling β-tubulin using anti-β-tubulin primary antibody and
AlexaFluor 555 goat anti-rabbit secondary antibody (Figure 5.1). During metaphase, EYFPGPSM3 and β-tubulin appear to co-localize. However, it was difficult to resolve how specific
this co-localization was. Additionally, capturing cells undergoing mitosis was difficult using this
protocol as cells first needed to be transfected and allowed to recover before having their cell
cycles synced via removal and re-addition of serum-containing medium. For these reasons,
successive experiments labeled endogenous GPSM3 using an anti-GPSM3 primary antibody and
AlexaFluor 488 goat anti-rabbit secondary antibody. β-tubulin was stained using anti-β-tubulin
primary antibody and AlexaFluor 568 goat anti-mouse secondary antibody.
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Figure 5.1. Localization of EYFP-tagged GPSM3 during mitosis in HEK-293 cells. HEK293 cells were transfected with 1 µg EYFP-GPSM3 DNA plasmid. Cells were serum starved for
24 hours, and 20 hours after serum replacement cells were fixed and subjected to
immunofluorescent labeling. Cells were probed with anti-β-tubulin primary antibody (1:500),
followed by AlexaFluor 555 goat anti-rabbit secondary antibody (1:500). Nuclei were stained
using DAPI. Panels labeled in top left corners. N=3.
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